메뉴 건너뛰기




Volumn 3, Issue SUPPL. 5, 2008, Pages

Saudi guidelines on diagnosis and treatment of pulmonary arterial hypertension

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; AMBRISENTAN; ANTICOAGULANT AGENT; ARGININE; BERAPROST; BONE MORPHOGENETIC PROTEIN 2; BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; COCAINE; DIGITALIS; DIGOXIN; DIURETIC AGENT; DOBUTAMINE; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; GUANYLATE CYCLASE; ILOPROST; NITRIC OXIDE; OXYGEN; PHOSPHODIESTERASE INHIBITOR; PLACEBO; PROSTACYCLIN; SEROTONIN TRANSPORTER; SILDENAFIL; SITAXSENTAN; TADALAFIL; THROMBOXANE A2; UNIPROST; VARDENAFIL; VASODILATOR AGENT;

EID: 41949105559     PISSN: 18171737     EISSN: 19983557     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (15)

References (446)
  • 1
    • 2942522878 scopus 로고    scopus 로고
    • Clinical classification of pulmonary arterial hypertension
    • Simonneau G, Galie N, Rubin L. Clinical classification of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43:S5-12.
    • (2004) J Am Coll Cardiol , vol.43
    • Simonneau, G.1    Galie, N.2    Rubin, L.3
  • 2
    • 0025837793 scopus 로고
    • Survival in patients with primary pulmonary hypertension : Results from a national prospective registry
    • D'Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, et al. Survival in patients with primary pulmonary hypertension : Results from a national prospective registry. Ann Intern Med 1991;115:343-9.
    • (1991) Ann Intern Med , vol.115 , pp. 343-349
    • D'Alonzo, G.E.1    Barst, R.J.2    Ayres, S.M.3    Bergofsky, E.H.4    Brundage, B.H.5    Detre, K.M.6
  • 4
    • 0032617453 scopus 로고    scopus 로고
    • Prediction of life expectancy in patients with primary pulmonary hypertension: A retrospective nationwide survey from 1980-1990
    • Okada O, Tanabe N, Yasuda J, Yoshida Y, Katoh K, Yamamoto T, et al. Prediction of life expectancy in patients with primary pulmonary hypertension: A retrospective nationwide survey from 1980-1990. Intern Med 1999;38:12-6.
    • (1999) Intern Med , vol.38 , pp. 12-16
    • Okada, O.1    Tanabe, N.2    Yasuda, J.3    Yoshida, Y.4    Katoh, K.5    Yamamoto, T.6
  • 6
    • 0033817459 scopus 로고    scopus 로고
    • rd, Loyd JE, et al. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension: The International PPH Consortium. Nat Genet 2000;26:81-4.
    • rd, Loyd JE, et al. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension: The International PPH Consortium. Nat Genet 2000;26:81-4.
  • 7
    • 0033838125 scopus 로고    scopus 로고
    • Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene
    • Deng Z, Morse JH, Slager SL, Cuervo N, Moore KJ, Venetos G, et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet 2000;67:737-44.
    • (2000) Am J Hum Genet , vol.67 , pp. 737-744
    • Deng, Z.1    Morse, J.H.2    Slager, S.L.3    Cuervo, N.4    Moore, K.J.5    Venetos, G.6
  • 8
    • 33644865928 scopus 로고    scopus 로고
    • Bone morphogenetic protein receptor 2 signaling promotes pulmonary arterial endothelial cell survival: Implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension
    • Teichert-Kuliszewska K, Kutryk MJ, Kuliszewski MA, Karoubi G, Courtman DW, Zucco L, et al. Bone morphogenetic protein receptor 2 signaling promotes pulmonary arterial endothelial cell survival: Implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension. Circulation Res 2006;98:209-17.
    • (2006) Circulation Res , vol.98 , pp. 209-217
    • Teichert-Kuliszewska, K.1    Kutryk, M.J.2    Kuliszewski, M.A.3    Karoubi, G.4    Courtman, D.W.5    Zucco, L.6
  • 9
    • 2942579448 scopus 로고    scopus 로고
    • Primary pulmonary arterial hypertension: A look back
    • Fishman AP. Primary pulmonary arterial hypertension: A look back. J Am Coll Cardiol 2004;43:S2-4.
    • (2004) J Am Coll Cardiol , vol.43
    • Fishman, A.P.1
  • 10
    • 0024449294 scopus 로고
    • Histopathology of primary pulmonary hypertension: A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry
    • Pietra GG, Edwards WD, Kay JM, Rich S, Kernis J, Schloo B, et al. Histopathology of primary pulmonary hypertension: A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry. Circulation 1989;80:1198-206.
    • (1989) Circulation , vol.80 , pp. 1198-1206
    • Pietra, G.G.1    Edwards, W.D.2    Kay, J.M.3    Rich, S.4    Kernis, J.5    Schloo, B.6
  • 11
    • 20344362689 scopus 로고    scopus 로고
    • Dysfunctional smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension
    • Yang X, Long L, Southwood M, Rudarakanchana N, Upton PD, Jeffery TK, et al. Dysfunctional smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension. Circulation Res 2005;96:1053-63.
    • (2005) Circulation Res , vol.96 , pp. 1053-1063
    • Yang, X.1    Long, L.2    Southwood, M.3    Rudarakanchana, N.4    Upton, P.D.5    Jeffery, T.K.6
  • 12
    • 0034776773 scopus 로고    scopus 로고
    • Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension
    • Eddahibi S, Humbert M, Fadel E, Raffestin B, Darmon M, Capron F, et al. Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest 2001;108:1141-50.
    • (2001) J Clin Invest , vol.108 , pp. 1141-1150
    • Eddahibi, S.1    Humbert, M.2    Fadel, E.3    Raffestin, B.4    Darmon, M.5    Capron, F.6
  • 15
    • 34547456414 scopus 로고    scopus 로고
    • The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted
    • Bonnet S, Rochefort G, Sutendra G, Archer SL, Haromy A, Webster L, et al. The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted. Proc Natl Acad Sci USA 2007;104:11418-23.
    • (2007) Proc Natl Acad Sci USA , vol.104 , pp. 11418-11423
    • Bonnet, S.1    Rochefort, G.2    Sutendra, G.3    Archer, S.L.4    Haromy, A.5    Webster, L.6
  • 16
    • 0342871960 scopus 로고    scopus 로고
    • Continuous infusion of prostacyclin normalizes plasma markers of endothelial cell injury and platelet aggregation in primary pulmonary hypertension
    • Friedman R, Mears JG, Barst RJ. Continuous infusion of prostacyclin normalizes plasma markers of endothelial cell injury and platelet aggregation in primary pulmonary hypertension. Circulation 1997;96:2782-4.
    • (1997) Circulation , vol.96 , pp. 2782-2784
    • Friedman, R.1    Mears, J.G.2    Barst, R.J.3
  • 18
    • 0025041322 scopus 로고
    • Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension
    • Eisenberg PR, Lucore C, Kaufman L, Sobel BE, Jaffe AS, Rich S. Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension. Circulation 1990;82:841-7.
    • (1990) Circulation , vol.82 , pp. 841-847
    • Eisenberg, P.R.1    Lucore, C.2    Kaufman, L.3    Sobel, B.E.4    Jaffe, A.S.5    Rich, S.6
  • 19
    • 0000145994 scopus 로고
    • Primary pulmonary hypertension, with special reference to the vasoconstrictive factor
    • Wood P. Primary pulmonary hypertension, with special reference to the vasoconstrictive factor. Br Heart J 1958;20:557-70.
    • (1958) Br Heart J , vol.20 , pp. 557-570
    • Wood, P.1
  • 20
    • 1642453778 scopus 로고    scopus 로고
    • Endothelial dysfunction in pulmonary hypertension
    • Budhiraja R, Tuder RM, Hassoun PM. Endothelial dysfunction in pulmonary hypertension. Circulation 2004;109:159-65.
    • (2004) Circulation , vol.109 , pp. 159-165
    • Budhiraja, R.1    Tuder, R.M.2    Hassoun, P.M.3
  • 21
    • 0032478272 scopus 로고    scopus 로고
    • Endothelins and endothelin receptor antagonists: Therapeutic considerations for a novel class of cardiovascular drugs
    • Verhaar MC, Strachan FE, Newby DE, Cruden NL, Koomans HA, Rabelink TJ, et al. Endothelins and endothelin receptor antagonists: Therapeutic considerations for a novel class of cardiovascular drugs. Circulation 1998;97:752-6.
    • (1998) Circulation , vol.97 , pp. 752-756
    • Verhaar, M.C.1    Strachan, F.E.2    Newby, D.E.3    Cruden, N.L.4    Koomans, H.A.5    Rabelink, T.J.6
  • 22
    • 0030814723 scopus 로고    scopus 로고
    • The orally active nonpeptide endothelin A-receptor antagonist A-127722 prevents and reverses hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling in Sprague-Dawley rats
    • Chen SJ, Chen YF, Opgenorth TJ, Wessale JL, Meng QC, Durand J, et al. The orally active nonpeptide endothelin A-receptor antagonist A-127722 prevents and reverses hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling in Sprague-Dawley rats. J Cardiovasc Pharmacol 1997;29:713-25.
    • (1997) J Cardiovasc Pharmacol , vol.29 , pp. 713-725
    • Chen, S.J.1    Chen, Y.F.2    Opgenorth, T.J.3    Wessale, J.L.4    Meng, Q.C.5    Durand, J.6
  • 24
    • 0034776773 scopus 로고    scopus 로고
    • Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension
    • Eddahibi S, Humbert M, Fadel E, Raffestin B, Darmon M, Capron F, et al. Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest 2001;108:1141-50.
    • (2001) J Clin Invest , vol.108 , pp. 1141-1150
    • Eddahibi, S.1    Humbert, M.2    Fadel, E.3    Raffestin, B.4    Darmon, M.5    Capron, F.6
  • 25
    • 0035676884 scopus 로고    scopus 로고
    • Pulmonary vascular remodeling: A target for therapeutic intervention in pulmonary hypertension
    • Jeffery TK, Wanstall JC. Pulmonary vascular remodeling: A target for therapeutic intervention in pulmonary hypertension. Pharmacol Ther 2001;92:1-20.
    • (2001) Pharmacol Ther , vol.92 , pp. 1-20
    • Jeffery, T.K.1    Wanstall, J.C.2
  • 26
    • 0037044398 scopus 로고    scopus 로고
    • Vascular endothelin-B receptor system in vivo plays a favorable inhibitory role in vascular remodeling after injury revealed by endothelin-B receptor-Knockout mice
    • Murakoshi N, Miyauchi T, Kakinuma Y, Ohuchi T, Goto K, Yanagisawa M, et al. Vascular endothelin-B receptor system in vivo plays a favorable inhibitory role in vascular remodeling after injury revealed by endothelin-B receptor-Knockout mice. Circulation 2002;106:1991-8.
    • (2002) Circulation , vol.106 , pp. 1991-1998
    • Murakoshi, N.1    Miyauchi, T.2    Kakinuma, Y.3    Ohuchi, T.4    Goto, K.5    Yanagisawa, M.6
  • 27
    • 0030814723 scopus 로고    scopus 로고
    • The orally active nonpeptide endothelin A-receptor antagonist A-127722 prevents and reverses hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling in Sprague-Dawley rats
    • Chen SJ, Chen YF, Opgenorth TJ, Wessale JL, Meng QC, Durand J, et al. The orally active nonpeptide endothelin A-receptor antagonist A-127722 prevents and reverses hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling in Sprague-Dawley rats. J Cardiovasc Pharmacol 1997;29:713-25.
    • (1997) J Cardiovasc Pharmacol , vol.29 , pp. 713-725
    • Chen, S.J.1    Chen, Y.F.2    Opgenorth, T.J.3    Wessale, J.L.4    Meng, Q.C.5    Durand, J.6
  • 28
    • 0033578451 scopus 로고    scopus 로고
    • Acute right ventricular dilatation in response to ischemia significantly impairs left ventricular systolic performance
    • Brookes C, Ravn H, White P, Moeldrup U, Oldershaw P, Redington A. Acute right ventricular dilatation in response to ischemia significantly impairs left ventricular systolic performance. Circulation 1999;100:761-7.
    • (1999) Circulation , vol.100 , pp. 761-767
    • Brookes, C.1    Ravn, H.2    White, P.3    Moeldrup, U.4    Oldershaw, P.5    Redington, A.6
  • 32
    • 0035038492 scopus 로고    scopus 로고
    • Pulmonary hypertension in systemic sclerosis: Risk factors for progression and consequences for survival
    • MacGregor AJ, Canavan R, Knight C, Denton CP, Davar J, Coghlan J, et al. Pulmonary hypertension in systemic sclerosis: Risk factors for progression and consequences for survival. Rheumatology (Oxford) 2001;40:453-9.
    • (2001) Rheumatology (Oxford) , vol.40 , pp. 453-459
    • MacGregor, A.J.1    Canavan, R.2    Knight, C.3    Denton, C.P.4    Davar, J.5    Coghlan, J.6
  • 33
    • 3142692425 scopus 로고    scopus 로고
    • Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines
    • McGoon M, Gutterman D, Steen V, Barst R, McCrory DC, Fortin TA, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004;126;14S-34S.
    • (2004) Chest , vol.126
    • McGoon, M.1    Gutterman, D.2    Steen, V.3    Barst, R.4    McCrory, D.C.5    Fortin, T.A.6
  • 34
    • 0036040921 scopus 로고    scopus 로고
    • Electrocardiography to define clinical status in primary pulmonary hypertension and pulmonary arterial hypertension secondary to collagen vascular disease
    • Ahearn GS, Tapson VF, Rebeiz A, Greenfield JC Jr. Electrocardiography to define clinical status in primary pulmonary hypertension and pulmonary arterial hypertension secondary to collagen vascular disease. Chest 2002;122:524-7.
    • (2002) Chest , vol.122 , pp. 524-527
    • Ahearn, G.S.1    Tapson, V.F.2    Rebeiz, A.3    Greenfield Jr., J.C.4
  • 36
    • 0021821553 scopus 로고    scopus 로고
    • rd, Hoeck BE, Chitwood WR Jr, Lyerly HK, Sabiston DC Jr, Chen JT. Radiographic findings in pulmonary hypertension from unresolved embolism. AJR Am J Roentgenol 1985;144:681-6.
    • rd, Hoeck BE, Chitwood WR Jr, Lyerly HK, Sabiston DC Jr, Chen JT. Radiographic findings in pulmonary hypertension from unresolved embolism. AJR Am J Roentgenol 1985;144:681-6.
  • 37
    • 0030331577 scopus 로고    scopus 로고
    • Pulmonary hypertension in patients with chronic pulmonary thromboembolism: Chest radiograph and CT evaluation before and after surgery
    • Schmidt HC, Kauczor HU, Schild HH, Renner C, Kirchhoff E, Lang P, et al. Pulmonary hypertension in patients with chronic pulmonary thromboembolism: Chest radiograph and CT evaluation before and after surgery. Eur Radiol 1996;6: 817-25.
    • (1996) Eur Radiol , vol.6 , pp. 817-825
    • Schmidt, H.C.1    Kauczor, H.U.2    Schild, H.H.3    Renner, C.4    Kirchhoff, E.5    Lang, P.6
  • 38
    • 0026676156 scopus 로고
    • Echocardiographic evaluation of pulmonary arterial hypertension in patients with progressive systemic sclerosis and related syndromes
    • Murata I, Kihara H, Shinohara S, Ito K. Echocardiographic evaluation of pulmonary arterial hypertension in patients with progressive systemic sclerosis and related syndromes. Jpn Circ J 1992;56:983-91.
    • (1992) Jpn Circ J , vol.56 , pp. 983-991
    • Murata, I.1    Kihara, H.2    Shinohara, S.3    Ito, K.4
  • 39
    • 8244225826 scopus 로고    scopus 로고
    • Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension
    • Hinderliter AL, Willis PW 4th, Barst RJ, Rich S, Rubin LJ, Badesch DB, et al. Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Circulation 1997;95:1479-86.
    • (1997) Circulation , vol.95 , pp. 1479-1486
    • Hinderliter, A.L.1    Willis 4th, P.W.2    Barst, R.J.3    Rich, S.4    Rubin, L.J.5    Badesch, D.B.6
  • 43
    • 0033931829 scopus 로고    scopus 로고
    • Accuracy of Doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates
    • Kim WR, Krowka MJ, Plevak DJ, Lee J, Rettke SR, Frantz RP, et al. Accuracy of Doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates. Liver Transpl 2000;6:453-8.
    • (2000) Liver Transpl , vol.6 , pp. 453-458
    • Kim, W.R.1    Krowka, M.J.2    Plevak, D.J.3    Lee, J.4    Rettke, S.R.5    Frantz, R.P.6
  • 44
    • 0030856433 scopus 로고    scopus 로고
    • Primary pulmonary hypertension: Improved long-term effects and survival with continuous intravenous epoprostenol infusion
    • Shapiro SM, Oudiz RJ, Cao T, Romano MA, Beckmann XJ, Georgiou D, et al. Primary pulmonary hypertension: Improved long-term effects and survival with continuous intravenous epoprostenol infusion. J Am Coll Cardiol 1997;30:343-9.
    • (1997) J Am Coll Cardiol , vol.30 , pp. 343-349
    • Shapiro, S.M.1    Oudiz, R.J.2    Cao, T.3    Romano, M.A.4    Beckmann, X.J.5    Georgiou, D.6
  • 46
    • 0021143486 scopus 로고
    • Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation
    • Yock PG, Popp RL. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 1984;70:657-62.
    • (1984) Circulation , vol.70 , pp. 657-662
    • Yock, P.G.1    Popp, R.L.2
  • 47
    • 0022355748 scopus 로고
    • Continuous wave Doppler determination of right ventricular pressure: A simultaneous Doppler-catheterization study in 127 patients
    • Currie PJ, Seward JB, Chan KL, Fyfe DA, Hagler DJ, Mair DD, et al. Continuous wave Doppler determination of right ventricular pressure: A simultaneous Doppler-catheterization study in 127 patients. J Am Coll Cardiol 1985;6:750-6.
    • (1985) J Am Coll Cardiol , vol.6 , pp. 750-756
    • Currie, P.J.1    Seward, J.B.2    Chan, K.L.3    Fyfe, D.A.4    Hagler, D.J.5    Mair, D.D.6
  • 49
    • 0022608631 scopus 로고
    • Prediction of pulmonary arterial pressure in adults by pulsed Doppler echocardiography
    • Isobe M, Yazaki Y, Takaku F, Koizumi K, Hara K, Tsuneyoshi H, et al. Prediction of pulmonary arterial pressure in adults by pulsed Doppler echocardiography. Am J Cardiol 1986;57:316-21.
    • (1986) Am J Cardiol , vol.57 , pp. 316-321
    • Isobe, M.1    Yazaki, Y.2    Takaku, F.3    Koizumi, K.4    Hara, K.5    Tsuneyoshi, H.6
  • 50
    • 0030967492 scopus 로고    scopus 로고
    • Shortening of Doppler-derived deceleration time of early diastolic transmitral flow in the presence of pulmonary hypertension through ventricular interaction
    • Nagaya N, Satoh T, Uematsu M, Okano Y, Kyotani S, Nakanishi N, et al. Shortening of Doppler-derived deceleration time of early diastolic transmitral flow in the presence of pulmonary hypertension through ventricular interaction. Am J Cardiol 1997;79:1502-6.
    • (1997) Am J Cardiol , vol.79 , pp. 1502-1506
    • Nagaya, N.1    Satoh, T.2    Uematsu, M.3    Okano, Y.4    Kyotani, S.5    Nakanishi, N.6
  • 51
  • 52
    • 25444481627 scopus 로고    scopus 로고
    • Systolic right ventricular function assessment by pulsed wave tissue Doppler imaging of the tricuspid annulus
    • Tüller D, Steiner M, Wahl A, Kabok M, Seiler C. Systolic right ventricular function assessment by pulsed wave tissue Doppler imaging of the tricuspid annulus. Swiss Med Wkly 2005;135:461-8.
    • (2005) Swiss Med Wkly , vol.135 , pp. 461-468
    • Tüller, D.1    Steiner, M.2    Wahl, A.3    Kabok, M.4    Seiler, C.5
  • 53
    • 33746780016 scopus 로고    scopus 로고
    • Right ventricular function assessed by two-dimensional strain and tissue doppler echocardiography in patients with pulmonary arterial hypertension and effect of vasodilator therapy
    • Borges AC, Knebel F, Eddicks S, Panda A, Schattke S, Witt C, et al. Right ventricular function assessed by two-dimensional strain and tissue doppler echocardiography in patients with pulmonary arterial hypertension and effect of vasodilator therapy. Am J Cardiol 2006;98:530-4.
    • (2006) Am J Cardiol , vol.98 , pp. 530-534
    • Borges, A.C.1    Knebel, F.2    Eddicks, S.3    Panda, A.4    Schattke, S.5    Witt, C.6
  • 54
    • 0344837813 scopus 로고    scopus 로고
    • Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension
    • Galie N, Hinderliter AL, Torbicki A, Fourme T, Simonneau G, Pulido T, et al. Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension. J Am Coll Cardiol 2003;41:1380-6.
    • (2003) J Am Coll Cardiol , vol.41 , pp. 1380-1386
    • Galie, N.1    Hinderliter, A.L.2    Torbicki, A.3    Fourme, T.4    Simonneau, G.5    Pulido, T.6
  • 55
    • 0027982543 scopus 로고
    • The management of pulmonary hypertension secondary to chronic thromboembolic disease
    • Viner SM, Bagg BR, Auger WR, Ford GT. The management of pulmonary hypertension secondary to chronic thromboembolic disease. Prog Cardiovasc Dis 1994;37:79-92.
    • (1994) Prog Cardiovasc Dis , vol.37 , pp. 79-92
    • Viner, S.M.1    Bagg, B.R.2    Auger, W.R.3    Ford, G.T.4
  • 57
    • 0029781467 scopus 로고    scopus 로고
    • Parenchymal scarring is associated with restrictive spirometric defects in patients with chronic thromboembolic pulmonary hypertension
    • Morris TA, Auger WR, Ysrael MZ, Olson LK, Channick RN, Fedullo PF, et al. Parenchymal scarring is associated with restrictive spirometric defects in patients with chronic thromboembolic pulmonary hypertension. Chest 1996;110:399-403.
    • (1996) Chest , vol.110 , pp. 399-403
    • Morris, T.A.1    Auger, W.R.2    Ysrael, M.Z.3    Olson, L.K.4    Channick, R.N.5    Fedullo, P.F.6
  • 59
    • 0033898873 scopus 로고    scopus 로고
    • Diffusion capacity and haemodynamics in primary and chronic thromboembolic pulmonary hypertension
    • Steenhuis LH, Groen HJ, Koeter GH, van der Mark TW. Diffusion capacity and haemodynamics in primary and chronic thromboembolic pulmonary hypertension. Eur Respir J 2000;16:276-81.
    • (2000) Eur Respir J , vol.16 , pp. 276-281
    • Steenhuis, L.H.1    Groen, H.J.2    Koeter, G.H.3    van der Mark, T.W.4
  • 61
    • 0035035768 scopus 로고    scopus 로고
    • GOLD Scientific Committee. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary
    • Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS; GOLD Scientific Committee. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256-76.
    • (2001) Am J Respir Crit Care Med , vol.163 , pp. 1256-1276
    • Pauwels, R.A.1    Buist, A.S.2    Calverley, P.M.3    Jenkins, C.R.4    Hurd, S.S.5
  • 62
    • 0030886936 scopus 로고    scopus 로고
    • Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: Correlation with pathologic scoring
    • Kazerooni EA, Martinez FJ, Flint A, Jamadar DA, Gross BH, Spizarny DL, et al. Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: Correlation with pathologic scoring. AJR Am J Roentgenol 1997;169:977-83.
    • (1997) AJR Am J Roentgenol , vol.169 , pp. 977-983
    • Kazerooni, E.A.1    Martinez, F.J.2    Flint, A.3    Jamadar, D.A.4    Gross, B.H.5    Spizarny, D.L.6
  • 63
    • 0027982543 scopus 로고
    • The management of pulmonary hypertension secondary to chronic thromboembolic disease
    • Viner SM, Bagg BR, Auger WR, Ford GT. The management of pulmonary hypertension secondary to chronic thromboembolic disease. Prog Cardiovasc Dis 1994;37:79-92.
    • (1994) Prog Cardiovasc Dis , vol.37 , pp. 79-92
    • Viner, S.M.1    Bagg, B.R.2    Auger, W.R.3    Ford, G.T.4
  • 65
    • 0028357077 scopus 로고
    • Ventilation-perfusion lung scanning in the evaluation of pulmonary hypertension
    • Worsley DF, Palevsky HI, Alavi A. Ventilation-perfusion lung scanning in the evaluation of pulmonary hypertension. J Nucl Med 1994;35:793-6.
    • (1994) J Nucl Med , vol.35 , pp. 793-796
    • Worsley, D.F.1    Palevsky, H.I.2    Alavi, A.3
  • 66
    • 0030971635 scopus 로고    scopus 로고
    • Accuracy of MR angiography compared with radionuclide scanning in identifying the cause of pulmonary arterial hypertension
    • Bergin CJ, Hauschildt J, Rios G, Belezzuoli EV, Huynh T, Channick RN. Accuracy of MR angiography compared with radionuclide scanning in identifying the cause of pulmonary arterial hypertension. AJR Am J Roentgenol 1997;168:1549-55.
    • (1997) AJR Am J Roentgenol , vol.168 , pp. 1549-1555
    • Bergin, C.J.1    Hauschildt, J.2    Rios, G.3    Belezzuoli, E.V.4    Huynh, T.5    Channick, R.N.6
  • 67
    • 0022479050 scopus 로고
    • Primary pulmonary hypertension: Radiographic and scintigraphic patterns of histologic subtypes
    • Rich S, Pietra GG, Kieras K, Hart K, Brundage BH. Primary pulmonary hypertension: Radiographic and scintigraphic patterns of histologic subtypes. Ann Intern Med 1986;105:499-502.
    • (1986) Ann Intern Med , vol.105 , pp. 499-502
    • Rich, S.1    Pietra, G.G.2    Kieras, K.3    Hart, K.4    Brundage, B.H.5
  • 68
    • 0023950147 scopus 로고
    • Perfusion scanfindings understate the severity of angiographic and hemodynamiccompromise in chronic thromboembolic pulmonary hypertension
    • Ryan KL, Fedullo PF, Davis GB, Vasquez TE, Moser KM. Perfusion scanfindings understate the severity of angiographic and hemodynamiccompromise in chronic thromboembolic pulmonary hypertension. Chest 1988;93:1180-5.
    • (1988) Chest , vol.93 , pp. 1180-1185
    • Ryan, K.L.1    Fedullo, P.F.2    Davis, G.B.3    Vasquez, T.E.4    Moser, K.M.5
  • 69
    • 0346957012 scopus 로고    scopus 로고
    • Pulmonary hypertension: CT findings in pulmonary veno-occlusive disease
    • Resten A, Maitre S, Capron F, Simonneau G, Musset D. Pulmonary hypertension: CT findings in pulmonary veno-occlusive disease. J Radiol 2003;84:1739-45.
    • (2003) J Radiol , vol.84 , pp. 1739-1745
    • Resten, A.1    Maitre, S.2    Capron, F.3    Simonneau, G.4    Musset, D.5
  • 72
    • 0032699428 scopus 로고    scopus 로고
    • Identifying the cause of unilateral hypoperfusion in patients suspected to have chronic pulmonary thromboembolism: Diagnostic accuracy of helical CT and conventional angiography
    • Bergin CJ, Hauschildt JP, Brown MA, Channick RN, Fedullo PF. Identifying the cause of unilateral hypoperfusion in patients suspected to have chronic pulmonary thromboembolism: Diagnostic accuracy of helical CT and conventional angiography. Radiology 1999;213:743-9.
    • (1999) Radiology , vol.213 , pp. 743-749
    • Bergin, C.J.1    Hauschildt, J.P.2    Brown, M.A.3    Channick, R.N.4    Fedullo, P.F.5
  • 75
    • 0029991903 scopus 로고    scopus 로고
    • MR imaging of pulmonary hypertension and right ventricular dysfunction
    • Boxt LM. MR imaging of pulmonary hypertension and right ventricular dysfunction. Magn Reson Imaging Clin North Am 1996;4:307-25.
    • (1996) Magn Reson Imaging Clin North Am , vol.4 , pp. 307-325
    • Boxt, L.M.1
  • 76
    • 0027197851 scopus 로고
    • Detection and quantification of pulmonary artery hypertension with MR imaging: Results in 23 patients
    • Frank H, Globits S, Glogar D, Neuhold A, Kneussl M, Mlczoch J. Detection and quantification of pulmonary artery hypertension with MR imaging: Results in 23 patients. AJR Am J Roentgenol 1993;161:27-31.
    • (1993) AJR Am J Roentgenol , vol.161 , pp. 27-31
    • Frank, H.1    Globits, S.2    Glogar, D.3    Neuhold, A.4    Kneussl, M.5    Mlczoch, J.6
  • 77
    • 0024757409 scopus 로고
    • Primary pulmonary hypertension: The risk and benefit of lung biopsy
    • Nicod P, Moser KM. Primary pulmonary hypertension: The risk and benefit of lung biopsy. Circulation 1989;80:1486-8.
    • (1989) Circulation , vol.80 , pp. 1486-1488
    • Nicod, P.1    Moser, K.M.2
  • 79
    • 3042595558 scopus 로고    scopus 로고
    • End-points for clinical trials in pulmonary arterial hypertension
    • Peacock A, Naeije R, Galie N, Reeves JT. End-points for clinical trials in pulmonary arterial hypertension. Eur Respir J 2004;23: 947-53.
    • (2004) Eur Respir J , vol.23 , pp. 947-953
    • Peacock, A.1    Naeije, R.2    Galie, N.3    Reeves, J.T.4
  • 82
    • 0346820946 scopus 로고    scopus 로고
    • Who benefits from long-term calcium-channel blocker therapy in primary pulmonary hypertension?
    • Sitbon O, Humbert M, Ioos V. Who benefits from long-term calcium-channel blocker therapy in primary pulmonary hypertension? Am J Respir Crit Care Med 2003;167.
    • (2003) Am J Respir Crit Care Med , pp. 167
    • Sitbon, O.1    Humbert, M.2    Ioos, V.3
  • 83
    • 0037151645 scopus 로고    scopus 로고
    • Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: Prognostic factors and survival
    • Sitbon O, Humbert M, Nunes H, Parent F, Garcia G, Hervé P, et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: Prognostic factors and survival. J Am Coll Cardiol 2002;40:780-8.
    • (2002) J Am Coll Cardiol , vol.40 , pp. 780-788
    • Sitbon, O.1    Humbert, M.2    Nunes, H.3    Parent, F.4    Garcia, G.5    Hervé, P.6
  • 84
    • 0031842301 scopus 로고    scopus 로고
    • Long-term intravenous prostaglandin (epoprostenol or iloprost) for treatment of severe pulmonary hypertension
    • Higenbottam T, Butt AY, McMahon A, Westerbeck R, Sharples L. Long-term intravenous prostaglandin (epoprostenol or iloprost) for treatment of severe pulmonary hypertension. Heart 1998;80:151-5.
    • (1998) Heart , vol.80 , pp. 151-155
    • Higenbottam, T.1    Butt, A.Y.2    McMahon, A.3    Westerbeck, R.4    Sharples, L.5
  • 85
    • 0034107636 scopus 로고    scopus 로고
    • Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension: Comparison with cardiopulmonary exercise testing
    • Miyamoto S, Nagaya N, Satoh T, Kyotani S, Sakamaki F, Fujita M, et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension: Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 2000;161:487-92.
    • (2000) Am J Respir Crit Care Med , vol.161 , pp. 487-492
    • Miyamoto, S.1    Nagaya, N.2    Satoh, T.3    Kyotani, S.4    Sakamaki, F.5    Fujita, M.6
  • 86
    • 0037118681 scopus 로고    scopus 로고
    • Assessment of survival in patients with primary pulmonary hypertension: Importance of cardiopulmonary exercise testing
    • Wensel R, Opitz CF, Anker SD, Winkler J, Höffken G, Kleber FX, et al. Assessment of survival in patients with primary pulmonary hypertension: Importance of cardiopulmonary exercise testing. Circulation 2002;106:319-24.
    • (2002) Circulation , vol.106 , pp. 319-324
    • Wensel, R.1    Opitz, C.F.2    Anker, S.D.3    Winkler, J.4    Höffken, G.5    Kleber, F.X.6
  • 87
    • 0036800014 scopus 로고    scopus 로고
    • The new clinical trials on pharmacological treatment in pulmonary arterial hypertension
    • Galie N, Manes A, Branzi A. The new clinical trials on pharmacological treatment in pulmonary arterial hypertension. Eur Respir J 2002;20:1037-49.
    • (2002) Eur Respir J , vol.20 , pp. 1037-1049
    • Galie, N.1    Manes, A.2    Branzi, A.3
  • 89
    • 0035019203 scopus 로고    scopus 로고
    • Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension
    • Paciocco G, Martinez FJ, Bossone E, Pielsticker E, Gillespie B, Rubenfire M. Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension. Eur Respir J 2001;17:647-52.
    • (2001) Eur Respir J , vol.17 , pp. 647-652
    • Paciocco, G.1    Martinez, F.J.2    Bossone, E.3    Pielsticker, E.4    Gillespie, B.5    Rubenfire, M.6
  • 90
    • 0037058867 scopus 로고    scopus 로고
    • Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death
    • Gitt AK, Wasserman K, Kilkowski C, Kleemann T, Kilkowski A, Bangert M, et al. Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death. Circulation 2002;106:3079-84.
    • (2002) Circulation , vol.106 , pp. 3079-3084
    • Gitt, A.K.1    Wasserman, K.2    Kilkowski, C.3    Kleemann, T.4    Kilkowski, A.5    Bangert, M.6
  • 91
    • 0033566838 scopus 로고    scopus 로고
    • Hinderliter AL, Willis PW 4th, Long W, Clarke WR, Ralph D, Caldwell EJ, et al. Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension. Am J Cardiol 1999;84:481-4,A10.
    • Hinderliter AL, Willis PW 4th, Long W, Clarke WR, Ralph D, Caldwell EJ, et al. Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension. Am J Cardiol 1999;84:481-4,A10.
  • 92
    • 0032076759 scopus 로고    scopus 로고
    • Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension
    • Yeo TC, Dujardin KS, Tei C, Mahoney DW, McGoon MD, Seward JB. Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension. Am J Cardiol 1998;81:1157-61.
    • (1998) Am J Cardiol , vol.81 , pp. 1157-1161
    • Yeo, T.C.1    Dujardin, K.S.2    Tei, C.3    Mahoney, D.W.4    McGoon, M.D.5    Seward, J.B.6
  • 94
    • 0021917699 scopus 로고
    • Magnitude and implications of spontaneous hemodynamic variability in primary pulmonary hypertension
    • Rich S, D'Alonzo GE, Dantzker DR, Levy PS. Magnitude and implications of spontaneous hemodynamic variability in primary pulmonary hypertension. Am J Cardiol 1985;55:159-63
    • (1985) Am J Cardiol , vol.55 , pp. 159-163
    • Rich, S.1    D'Alonzo, G.E.2    Dantzker, D.R.3    Levy, P.S.4
  • 95
    • 33845343982 scopus 로고    scopus 로고
    • Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers
    • Hoeper MH, Lee SH, Voswinckel R, Palazzini M, Jais X, Marinelli A, et al. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol 2006;48:2546-52.
    • (2006) J Am Coll Cardiol , vol.48 , pp. 2546-2552
    • Hoeper, M.H.1    Lee, S.H.2    Voswinckel, R.3    Palazzini, M.4    Jais, X.5    Marinelli, A.6
  • 96
    • 0024804879 scopus 로고
    • The acute administration of vasodilators in primary pulmonary hypertension: Experience from the National Institutes of Health Registry on Primary Pulmonary Hypertension
    • Weir EK, Rubin LJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, et al. The acute administration of vasodilators in primary pulmonary hypertension: Experience from the National Institutes of Health Registry on Primary Pulmonary Hypertension. Am Rev Respir Dis 1989;140:1623-30.
    • (1989) Am Rev Respir Dis , vol.140 , pp. 1623-1630
    • Weir, E.K.1    Rubin, L.J.2    Ayres, S.M.3    Bergofsky, E.H.4    Brundage, B.H.5    Detre, K.M.6
  • 98
    • 0346820946 scopus 로고    scopus 로고
    • Who benefits from long-term calcium-channel blocker therapy in primary pulmonary hypertension?
    • Sitbon O, Humbert M, Ioos V. Who benefits from long-term calcium-channel blocker therapy in primary pulmonary hypertension? Am J Respir Crit Care Med 2003;167.
    • (2003) Am J Respir Crit Care Med , pp. 167
    • Sitbon, O.1    Humbert, M.2    Ioos, V.3
  • 99
    • 2942544581 scopus 로고    scopus 로고
    • Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension
    • Galie N, Seeger W, Naeije R, Simonneau G, Rubin LJ. Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol 2004;43: 81S-8S.
    • (2004) J Am Coll Cardiol , vol.43
    • Galie, N.1    Seeger, W.2    Naeije, R.3    Simonneau, G.4    Rubin, L.J.5
  • 101
    • 20544448927 scopus 로고    scopus 로고
    • Long-term response to calcium channel blockers in idiopathic pulmonary hypertension
    • Stibon O, Humber M, Jais X, Ioos V, Hamid AM, Provencher S, et al. Long-term response to calcium channel blockers in idiopathic pulmonary hypertension. Circulation 2005;111:3105-11.
    • (2005) Circulation , vol.111 , pp. 3105-3111
    • Stibon, O.1    Humber, M.2    Jais, X.3    Ioos, V.4    Hamid, A.M.5    Provencher, S.6
  • 102
    • 0030024879 scopus 로고    scopus 로고
    • Clinical significance of the pulmonary vasodilator response during short-term infusion of prostacyclin in primary pulmonary hypertension
    • Raffy O, Azarian R, Brenot F, Parent F, Sitbon O, Petitpretz P, et al. Clinical significance of the pulmonary vasodilator response during short-term infusion of prostacyclin in primary pulmonary hypertension. Circulation 1996;93:484-8.
    • (1996) Circulation , vol.93 , pp. 484-488
    • Raffy, O.1    Azarian, R.2    Brenot, F.3    Parent, F.4    Sitbon, O.5    Petitpretz, P.6
  • 103
    • 0034702908 scopus 로고    scopus 로고
    • Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension
    • Nagaya N, Nishikimi T, Uematsu M, Satoh T, Kyotani S, Sakamaki F, et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 2000;102:865-70.
    • (2000) Circulation , vol.102 , pp. 865-870
    • Nagaya, N.1    Nishikimi, T.2    Uematsu, M.3    Satoh, T.4    Kyotani, S.5    Sakamaki, F.6
  • 104
    • 0035171979 scopus 로고    scopus 로고
    • Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension
    • Rubens C, Ewert R, Halank M, Wensel R, Orzechowski HD, Schultheiss HP, et al. Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension. Chest 2001;120:1562-9.
    • (2001) Chest , vol.120 , pp. 1562-1569
    • Rubens, C.1    Ewert, R.2    Halank, M.3    Wensel, R.4    Orzechowski, H.D.5    Schultheiss, H.P.6
  • 105
    • 0042433550 scopus 로고    scopus 로고
    • Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension
    • Torbicki A, Kurzyna M, Kuca P, Fijałkowska A, Sikora J, Florczyk M, et al. Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension. Circulation 2003;108:844-8.
    • (2003) Circulation , vol.108 , pp. 844-848
    • Torbicki, A.1    Kurzyna, M.2    Kuca, P.3    Fijałkowska, A.4    Sikora, J.5    Florczyk, M.6
  • 106
    • 0018417731 scopus 로고
    • Release of nucleosides from canine and human hearts as an index of prior schemia
    • Fox AC, Reed GE, Meilman H, Silk BB. Release of nucleosides from canine and human hearts as an index of prior schemia. Am J Cardiol 1979;43:52-8.
    • (1979) Am J Cardiol , vol.43 , pp. 52-58
    • Fox, A.C.1    Reed, G.E.2    Meilman, H.3    Silk, B.B.4
  • 107
    • 0016665063 scopus 로고
    • Release of adenosine by hypoxic canine lung tissue and its possible role in pulmonary circulation
    • Mentzer RM, Rubio R, Berne RM. Release of adenosine by hypoxic canine lung tissue and its possible role in pulmonary circulation. Am J Physiol 1975;229:1625-31.
    • (1975) Am J Physiol , vol.229 , pp. 1625-1631
    • Mentzer, R.M.1    Rubio, R.2    Berne, R.M.3
  • 108
    • 0032814812 scopus 로고    scopus 로고
    • Serum uric acid levels correlate with the severity and the mortality of primary pulmonary hypertension
    • Nagaya N, Uematsu M, Satoh T, Kyotani S, Sakamaki F, Nakanishi N, et al. Serum uric acid levels correlate with the severity and the mortality of primary pulmonary hypertension. Am J Respir Crit Care Med 1999;160:487-92.
    • (1999) Am J Respir Crit Care Med , vol.160 , pp. 487-492
    • Nagaya, N.1    Uematsu, M.2    Satoh, T.3    Kyotani, S.4    Sakamaki, F.5    Nakanishi, N.6
  • 110
    • 3142655693 scopus 로고    scopus 로고
    • Methodology and grading for pulmonary hypertension evidence review and guideline development
    • McCrory DC, Lewis SZ. Methodology and grading for pulmonary hypertension evidence review and guideline development. Chest 2004;126:11S-3S.
    • (2004) Chest , vol.126
    • McCrory, D.C.1    Lewis, S.Z.2
  • 111
    • 10044276295 scopus 로고    scopus 로고
    • Women and pulmonary arterial hypertension
    • Manes A, Galiè N, Branzi A. Women and pulmonary arterial hypertension. Eur Respir J 2003;8:219-27.
    • (2003) Eur Respir J , vol.8 , pp. 219-227
    • Manes, A.1    Galiè, N.2    Branzi, A.3
  • 113
    • 0031747446 scopus 로고    scopus 로고
    • Outcome of pulmonary vascular disease in pregnancy: A systematic overview from 1978 through 1996
    • Weiss BM, Zemp L, Seifert B, Hess OM. Outcome of pulmonary vascular disease in pregnancy: A systematic overview from 1978 through 1996. J Am Coll Cardiol 1998;31:1650-7.
    • (1998) J Am Coll Cardiol , vol.31 , pp. 1650-1657
    • Weiss, B.M.1    Zemp, L.2    Seifert, B.3    Hess, O.M.4
  • 114
    • 0037391856 scopus 로고    scopus 로고
    • Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology. Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J 2003;24:761-81
    • Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology. Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J 2003;24:761-81.
  • 115
    • 0027252006 scopus 로고
    • Successful management of labor and delivery in primary pulmonary hypertension
    • Nootens M, Rich S. Successful management of labor and delivery in primary pulmonary hypertension. Am J Cardiol 1993;71:1124-5.
    • (1993) Am J Cardiol , vol.71 , pp. 1124-1125
    • Nootens, M.1    Rich, S.2
  • 116
    • 9444287592 scopus 로고    scopus 로고
    • Appetite-suppressant drugs and the risk of primary pulmonary hypertension
    • Abenhaim L, Moride Y, Brenot F, Rich S, Benichou J, Kurz X, et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med 1996;335:609-16.
    • (1996) N Engl J Med , vol.335 , pp. 609-616
    • Abenhaim, L.1    Moride, Y.2    Brenot, F.3    Rich, S.4    Benichou, J.5    Kurz, X.6
  • 118
    • 0029131445 scopus 로고
    • Breaking bad news: Consensus guidelines for medical practitioners
    • Girgis A, Sanson-Fisher RW. Breaking bad news: Consensus guidelines for medical practitioners. J Clin Oncol 1995;13: 2449-56.
    • (1995) J Clin Oncol , vol.13 , pp. 2449-2456
    • Girgis, A.1    Sanson-Fisher, R.W.2
  • 120
    • 0023214786 scopus 로고
    • Natural history of pulmonary hemodynamics in primary pulmonary hypertension
    • Kanemoto N. Natural history of pulmonary hemodynamics in primary pulmonary hypertension. Am Heart J 1987;114:407-13
    • (1987) Am Heart J , vol.114 , pp. 407-413
    • Kanemoto, N.1
  • 122
    • 0030813510 scopus 로고    scopus 로고
    • The effect of anticoagulant therapy in primary and anorectic drug-induced pulmonary hypertension
    • Frank H, Mlczoch J, Huber K, Schuster E, Gurtner HP, Kneussl M. The effect of anticoagulant therapy in primary and anorectic drug-induced pulmonary hypertension. Chest 1997;112:714-21.
    • (1997) Chest , vol.112 , pp. 714-721
    • Frank, H.1    Mlczoch, J.2    Huber, K.3    Schuster, E.4    Gurtner, H.P.5    Kneussl, M.6
  • 124
    • 17144452827 scopus 로고    scopus 로고
    • Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease: A randomized, controlled trial
    • Badesch DB, Tapson VF, McGoon MD, Brundage BH, Rubin LJ, Wigley FM, et al. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease: A randomized, controlled trial. Ann Intern Med 2000;132:425-34.
    • (2000) Ann Intern Med , vol.132 , pp. 425-434
    • Badesch, D.B.1    Tapson, V.F.2    McGoon, M.D.3    Brundage, B.H.4    Rubin, L.J.5    Wigley, F.M.6
  • 125
    • 0031719459 scopus 로고    scopus 로고
    • The short-term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension
    • Rich S, Seidlitz M, Dodin E, Osimani D, Judd D, Genthner D, et al. The short-term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension. Chest 1998;114:787-92.
    • (1998) Chest , vol.114 , pp. 787-792
    • Rich, S.1    Seidlitz, M.2    Dodin, E.3    Osimani, D.4    Judd, D.5    Genthner, D.6
  • 126
    • 0020419835 scopus 로고
    • The effect of digoxin on exercise capacity and exercising cardiac function in cystic fibrosis
    • Coates AL, Desmond K, Asher MI, Hortop J, Beaudry PH. The effect of digoxin on exercise capacity and exercising cardiac function in cystic fibrosis. Chest 1982;82:543-7.
    • (1982) Chest , vol.82 , pp. 543-547
    • Coates, A.L.1    Desmond, K.2    Asher, M.I.3    Hortop, J.4    Beaudry, P.H.5
  • 127
    • 0026632785 scopus 로고
    • The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension
    • Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992;327:76-81.
    • (1992) N Engl J Med , vol.327 , pp. 76-81
    • Rich, S.1    Kaufmann, E.2    Levy, P.S.3
  • 128
    • 0023238042 scopus 로고
    • High-dose calcium channel-blocking therapy for primary pulmonary hypertension: Evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy
    • Rich S, Brundage BH. High-dose calcium channel-blocking therapy for primary pulmonary hypertension: Evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy. Circulation 1987;76:135-41.
    • (1987) Circulation , vol.76 , pp. 135-141
    • Rich, S.1    Brundage, B.H.2
  • 129
    • 20544448927 scopus 로고    scopus 로고
    • Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension
    • Sitbon O, Humbert M, Jaïs X, Ioos V, Hamid AM, Provencher S, et al. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation 2005;111:3105-11.
    • (2005) Circulation , vol.111 , pp. 3105-3111
    • Sitbon, O.1    Humbert, M.2    Jaïs, X.3    Ioos, V.4    Hamid, A.M.5    Provencher, S.6
  • 130
    • 0033537630 scopus 로고    scopus 로고
    • Vasodilator therapy for primary pulmonary hypertension in children
    • Barst RJ, Maislin G, Fishman AP. Vasodilator therapy for primary pulmonary hypertension in children. Circulation 1999;99:1197-208.
    • (1999) Circulation , vol.99 , pp. 1197-1208
    • Barst, R.J.1    Maislin, G.2    Fishman, A.P.3
  • 131
    • 4043161231 scopus 로고    scopus 로고
    • Outcomes in children with idiopathic pulmonary arterial hypertension
    • Yung D, Widlitz AC, Rosenzweig EB, et al. Outcomes in children with idiopathic pulmonary arterial hypertension. Circulation 2004;110:660-5.
    • (2004) Circulation , vol.110 , pp. 660-665
    • Yung, D.1    Widlitz, A.C.2    Rosenzweig, E.B.3
  • 132
    • 0025943997 scopus 로고
    • High dose titration of calcium channel blocking agents for primary pulmonary hypertension: Guidelines for short-term drug testing
    • Rich S, Kaufmann E. High dose titration of calcium channel blocking agents for primary pulmonary hypertension: Guidelines for short-term drug testing. J Am Coll Cardiol 1991;18:1323-7.
    • (1991) J Am Coll Cardiol , vol.18 , pp. 1323-1327
    • Rich, S.1    Kaufmann, E.2
  • 133
    • 0028839874 scopus 로고
    • Activation of thromboxane and prostacyclin receptors elicits opposing effects on vascular smooth muscle cell growth and mitogen-activated protein kinase signaling cascades
    • Jones DA, Benjamin CW, Linseman DA. Activation of thromboxane and prostacyclin receptors elicits opposing effects on vascular smooth muscle cell growth and mitogen-activated protein kinase signaling cascades. Mol Pharmacol 1995;48:890-6.
    • (1995) Mol Pharmacol , vol.48 , pp. 890-896
    • Jones, D.A.1    Benjamin, C.W.2    Linseman, D.A.3
  • 134
    • 0041353958 scopus 로고    scopus 로고
    • Prostanoids for pulmonary arterial hypertension
    • Galie N, Manes A, Branzi A. Prostanoids for pulmonary arterial hypertension. Am J Respir Med 2003;2:123-37.
    • (2003) Am J Respir Med , vol.2 , pp. 123-137
    • Galie, N.1    Manes, A.2    Branzi, A.3
  • 135
    • 0033614831 scopus 로고    scopus 로고
    • Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin 1 clearance and release in primary pulmonary hypertension
    • Langleben D, Barst RJ, Badesch D, Groves BM, Tapson VF, Murali S, et al. Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin 1 clearance and release in primary pulmonary hypertension. Circulation 1999;99:3266-71.
    • (1999) Circulation , vol.99 , pp. 3266-3271
    • Langleben, D.1    Barst, R.J.2    Badesch, D.3    Groves, B.M.4    Tapson, V.F.5    Murali, S.6
  • 136
    • 0030031888 scopus 로고    scopus 로고
    • A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension
    • Barst RJ, Rubin LJ, Long WA, McGoon MD, Rich S, Badesch DB, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 1996;334:296-302.
    • (1996) N Engl J Med , vol.334 , pp. 296-302
    • Barst, R.J.1    Rubin, L.J.2    Long, W.A.3    McGoon, M.D.4    Rich, S.5    Badesch, D.B.6
  • 137
    • 0032576672 scopus 로고    scopus 로고
    • Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension
    • McLaughlin VV, Genthner DE, Panella MM, Rich S. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. N Engl J Med 1998;338:273-7.
    • (1998) N Engl J Med , vol.338 , pp. 273-277
    • McLaughlin, V.V.1    Genthner, D.E.2    Panella, M.M.3    Rich, S.4
  • 138
    • 0036007307 scopus 로고    scopus 로고
    • Differential effects of stable prostacyclin analogues on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery
    • Clapp LH, Finney P, Turcato S, Tran S, Rubin LJ, Tinker A. Differential effects of stable prostacyclin analogues on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery. Am J Respir Cell Mol Biol 2002;26:194-201.
    • (2002) Am J Respir Cell Mol Biol , vol.26 , pp. 194-201
    • Clapp, L.H.1    Finney, P.2    Turcato, S.3    Tran, S.4    Rubin, L.J.5    Tinker, A.6
  • 139
    • 0025356811 scopus 로고
    • Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol): Results of a randomized trial
    • Rubin LJ, Mendoza J, Hood M, McGoon M, Barst R, Williams WB, et al. Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol): Results of a randomized trial. Ann Intern Med 1990;112:485-91.
    • (1990) Ann Intern Med , vol.112 , pp. 485-491
    • Rubin, L.J.1    Mendoza, J.2    Hood, M.3    McGoon, M.4    Barst, R.5    Williams, W.B.6
  • 140
    • 0033954110 scopus 로고    scopus 로고
    • Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus
    • Robbins IM, Gaine SP, Schilz R, Tapson VF, Rubin LJ, Loyd JE. Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus. Chest 2000;117:14-8.
    • (2000) Chest , vol.117 , pp. 14-18
    • Robbins, I.M.1    Gaine, S.P.2    Schilz, R.3    Tapson, V.F.4    Rubin, L.J.5    Loyd, J.E.6
  • 141
    • 0033522395 scopus 로고    scopus 로고
    • Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: A case series
    • McLaughlin VV, Genthner DE, Panella MM, Rich S. Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: A case series. Ann Intern Med 1999;130:740-3.
    • (1999) Ann Intern Med , vol.130 , pp. 740-743
    • McLaughlin, V.V.1    Genthner, D.E.2    Panella, M.M.3    Rich, S.4
  • 143
    • 0033679134 scopus 로고    scopus 로고
    • Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension
    • Aguilar RV, Farber HW. Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension. Am J Respir Crit Care Med 2000;162:1846-50.
    • (2000) Am J Respir Crit Care Med , vol.162 , pp. 1846-1850
    • Aguilar, R.V.1    Farber, H.W.2
  • 144
    • 0033551155 scopus 로고    scopus 로고
    • Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects
    • Rosenzweig EB, Kerstein D, Barst RJ. Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects. Circulation 1999;99:1858-65.
    • (1999) Circulation , vol.99 , pp. 1858-1865
    • Rosenzweig, E.B.1    Kerstein, D.2    Barst, R.J.3
  • 146
    • 0141688386 scopus 로고    scopus 로고
    • Successful management of pregnancy in a patient with eisenmenger syndrome with epoprostenol
    • Geohas C, McLaughlin VV. Successful management of pregnancy in a patient with eisenmenger syndrome with epoprostenol. Chest 2003;124:1170-3.
    • (2003) Chest , vol.124 , pp. 1170-1173
    • Geohas, C.1    McLaughlin, V.V.2
  • 147
    • 0033977505 scopus 로고    scopus 로고
    • A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension
    • Hoeper MM, Olschewski H, Ghofrani HA, Wilkens H, Winkler J, Borst MM, et al. A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. J Am Coll Cardiol 2000;35:176-82.
    • (2000) J Am Coll Cardiol , vol.35 , pp. 176-182
    • Hoeper, M.M.1    Olschewski, H.2    Ghofrani, H.A.3    Wilkens, H.4    Winkler, J.5    Borst, M.M.6
  • 150
    • 21544449424 scopus 로고    scopus 로고
    • Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension
    • Opitz CF, Wensel R, Winkler J, Halank M, Bruch L, Kleber FX, et al. Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension. Eur Heart J 2005;26:1895-902.
    • (2005) Eur Heart J , vol.26 , pp. 1895-1902
    • Opitz, C.F.1    Wensel, R.2    Winkler, J.3    Halank, M.4    Bruch, L.5    Kleber, F.X.6
  • 152
    • 0036283401 scopus 로고    scopus 로고
    • Clinical efficacy of sitaxsentan, an endothelin: A receptor antagonist, in patients with pulmonary arterial hypertension: Open-label pilot study
    • Barst RJ, Rich S, Widlitz A, Horn EM, McLaughlin V, McFarlin J. Clinical efficacy of sitaxsentan, an endothelin: A receptor antagonist, in patients with pulmonary arterial hypertension: Open-label pilot study. Chest 2002;121:1860-8.
    • (2002) Chest , vol.121 , pp. 1860-1868
    • Barst, R.J.1    Rich, S.2    Widlitz, A.3    Horn, E.M.4    McLaughlin, V.5    McFarlin, J.6
  • 153
    • 33745172176 scopus 로고    scopus 로고
    • Efficacy of long-term subcutaneous treprostinil sodium therapy in pulmonary hypertension
    • Lang I, Gomez-Sanchez M, Kneussl M, Naeije R, Escribano P, Skoro-Sajer N, et al. Efficacy of long-term subcutaneous treprostinil sodium therapy in pulmonary hypertension. Chest 2006;129:1636-43.
    • (2006) Chest , vol.129 , pp. 1636-1643
    • Lang, I.1    Gomez-Sanchez, M.2    Kneussl, M.3    Naeije, R.4    Escribano, P.5    Skoro-Sajer, N.6
  • 154
    • 33645119109 scopus 로고    scopus 로고
    • Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: A prospective, multicenter, open-label, 12-week trial
    • Tapson VF, Gomberg-Maitland M, McLaughlin VV, Benza RL, Widlitz AC, Krichman A, et al. Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: A prospective, multicenter, open-label, 12-week trial. Chest 2006;129:683-8.
    • (2006) Chest , vol.129 , pp. 683-688
    • Tapson, V.F.1    Gomberg-Maitland, M.2    McLaughlin, V.V.3    Benza, R.L.4    Widlitz, A.C.5    Krichman, A.6
  • 155
    • 0036569119 scopus 로고    scopus 로고
    • Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: A randomised, double-blind placebo-controlled trial
    • Galie N, Humbert M, Vachiery JL, Vizza CD, Kneussl M, Manes A, et al. Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: A randomised, double-blind placebo-controlled trial. J Am Coll Cardiol 2002;39:1496-502.
    • (2002) J Am Coll Cardiol , vol.39 , pp. 1496-1502
    • Galie, N.1    Humbert, M.2    Vachiery, J.L.3    Vizza, C.D.4    Kneussl, M.5    Manes, A.6
  • 157
    • 0026034713 scopus 로고
    • Increased plasma endothelin-1 in pulmonary hypertension: Marker or mediator of disease?
    • Stewart DJ, Levy RD, Cernacek P, Langleben D. Increased plasma endothelin-1 in pulmonary hypertension: Marker or mediator of disease? Ann Intern Med 1991;114:464-9.
    • (1991) Ann Intern Med , vol.114 , pp. 464-469
    • Stewart, D.J.1    Levy, R.D.2    Cernacek, P.3    Langleben, D.4
  • 158
  • 159
    • 0346492721 scopus 로고    scopus 로고
    • The endothelin system in pulmonary arterial hypertension
    • Galie N, Manes A, Branzi A. The endothelin system in pulmonary arterial hypertension. Cardiovasc Res 2004;61:227-37.
    • (2004) Cardiovasc Res , vol.61 , pp. 227-237
    • Galie, N.1    Manes, A.2    Branzi, A.3
  • 160
    • 0033537345 scopus 로고    scopus 로고
    • Endothelin antagonists
    • Benigni A, Remuzzi G. Endothelin antagonists. Lancet 1999;353:133-8.
    • (1999) Lancet , vol.353 , pp. 133-138
    • Benigni, A.1    Remuzzi, G.2
  • 161
    • 0027751994 scopus 로고
    • In vivo pharmacology of Ro 46-2005, the first synthetic nonpeptide endothelin receptor antagonist: Implications for endothelin physiology
    • Clozel M, Breu V, Gray GA, Löffler BM. In vivo pharmacology of Ro 46-2005, the first synthetic nonpeptide endothelin receptor antagonist: Implications for endothelin physiology. J Cardiovasc Pharmacol 1993;22:S377-9.
    • (1993) J Cardiovasc Pharmacol , vol.22
    • Clozel, M.1    Breu, V.2    Gray, G.A.3    Löffler, B.M.4
  • 162
    • 0000648942 scopus 로고    scopus 로고
    • Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary hypertension: A placebo-controlled study
    • Channick R, Badesch DB, Tapson VF, Simonneau G, Robbins I, Frost A, et al. Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary hypertension: A placebo-controlled study. J Heart Lung Transplant 2001;20:262-3.
    • (2001) J Heart Lung Transplant , vol.20 , pp. 262-263
    • Channick, R.1    Badesch, D.B.2    Tapson, V.F.3    Simonneau, G.4    Robbins, I.5    Frost, A.6
  • 164
    • 0035818316 scopus 로고    scopus 로고
    • Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: A randomised placebo-controlled study
    • Channick RN, Simonneau G, Sitbon O, Robbins IM, Frost A, Tapson VF, et al. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: A randomised placebo-controlled study. Lancet 2001;358:1119-23.
    • (2001) Lancet , vol.358 , pp. 1119-1123
    • Channick, R.N.1    Simonneau, G.2    Sitbon, O.3    Robbins, I.M.4    Frost, A.5    Tapson, V.F.6
  • 166
    • 27744444638 scopus 로고    scopus 로고
    • Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol
    • Sitbon O, McLaughlin VV, Badesch DB, Barst RJ, Black C, Galiè N, et al. Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol. Thorax 2005;60:1025-30.
    • (2005) Thorax , vol.60 , pp. 1025-1030
    • Sitbon, O.1    McLaughlin, V.V.2    Badesch, D.B.3    Barst, R.J.4    Black, C.5    Galiè, N.6
  • 168
    • 12844272424 scopus 로고    scopus 로고
    • Safety and tolerability of bosentan in adults with Eisenmenger physiology
    • Gatzoulis, MA, Rogers P, Li W, Harries C, Cramer D, Ward S, et al. Safety and tolerability of bosentan in adults with Eisenmenger physiology. Int J Cardiol 2005;98:147-51.
    • (2005) Int J Cardiol , vol.98 , pp. 147-151
    • Gatzoulis, M.A.1    Rogers, P.2    Li, W.3    Harries, C.4    Cramer, D.5    Ward, S.6
  • 169
    • 33746206340 scopus 로고    scopus 로고
    • Bosentan therapy in patients with Eisenmenger syndrome: A multicenter, double-blind, randomized, placebo-controlled study
    • Galie N, Beghetti M, Gatzoulis MA, Granton J, Berger RM, Lauer A, et al. Bosentan therapy in patients with Eisenmenger syndrome: A multicenter, double-blind, randomized, placebo-controlled study. Circulation 2006;114:48-54.
    • (2006) Circulation , vol.114 , pp. 48-54
    • Galie, N.1    Beghetti, M.2    Gatzoulis, M.A.3    Granton, J.4    Berger, R.M.5    Lauer, A.6
  • 170
    • 0344406959 scopus 로고    scopus 로고
    • Pharmacokinetics, safety and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension
    • Barst RJ, Ivy D, Dingemanse J, Widlitz A, Schmitt K, Doran A, et al. Pharmacokinetics, safety and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension. Clin Pharmacol Ther 2003;73:372-82.
    • (2003) Clin Pharmacol Ther , vol.73 , pp. 372-382
    • Barst, R.J.1    Ivy, D.2    Dingemanse, J.3    Widlitz, A.4    Schmitt, K.5    Doran, A.6
  • 173
    • 0035036050 scopus 로고    scopus 로고
    • The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: A potential mechanism for hepatic adverse reactions
    • Fattinger K, Funk C, Pantze M, Weber C, Reichen J, Stieger B, et al. The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: A potential mechanism for hepatic adverse reactions. Clin Pharmacol Ther 2001;69:223-31.
    • (2001) Clin Pharmacol Ther , vol.69 , pp. 223-231
    • Fattinger, K.1    Funk, C.2    Pantze, M.3    Weber, C.4    Reichen, J.5    Stieger, B.6
  • 176
    • 33646255654 scopus 로고    scopus 로고
    • Treatment of pulmonary arterial hypertension with the selective endothelin: A receptor antagonist sitaxsentan
    • Barst RJ, Langleben D, Badesch D, Frost A, Lawrence EC, Shapiro S, et al. Treatment of pulmonary arterial hypertension with the selective endothelin: A receptor antagonist sitaxsentan. J Am Coll Cardiol 2006;47:2049-56.
    • (2006) J Am Coll Cardiol , vol.47 , pp. 2049-2056
    • Barst, R.J.1    Langleben, D.2    Badesch, D.3    Frost, A.4    Lawrence, E.C.5    Shapiro, S.6
  • 179
    • 34249044429 scopus 로고    scopus 로고
    • ARIES-1: A placebo-controlled efficacy and safety study of ambrisentan in patients with pulmonary arterial hypertension
    • Oudiz R, Torres F, Frost A. ARIES-1: A placebo-controlled efficacy and safety study of ambrisentan in patients with pulmonary arterial hypertension. Chest 2006;130:121S
    • (2006) Chest , vol.130
    • Oudiz, R.1    Torres, F.2    Frost, A.3
  • 180
    • 33748078298 scopus 로고    scopus 로고
    • Ambrisentan improves exercise capacity and time to clinical worsening in patients with pulmonary arterial hypertension: Results of the ARIES- Cohort Study
    • Olschewski H, Galie N, Ghofrani HA. Ambrisentan improves exercise capacity and time to clinical worsening in patients with pulmonary arterial hypertension: Results of the ARIES- Cohort Study. Proc Am Thorac Soc 2006;3:A728.
    • (2006) Proc Am Thorac Soc , vol.3
    • Olschewski, H.1    Galie, N.2    Ghofrani, H.A.3
  • 181
    • 34249852488 scopus 로고    scopus 로고
    • No clinical relevant pharmacokinetic interaction between ambrisentan an sildenafil
    • Dufton C, Gerber MJ, Yin O. No clinical relevant pharmacokinetic interaction between ambrisentan an sildenafil. Chest 2006; 130:254S.
    • (2006) Chest , vol.130
    • Dufton, C.1    Gerber, M.J.2    Yin, O.3
  • 182
    • 34249855849 scopus 로고    scopus 로고
    • Ambrisentan has no clinically relevant effect on the pharmacokinetics or pharmacodynamics of warfarin
    • Gerber MJ, Dufton C, Pentikis H. Ambrisentan has no clinically relevant effect on the pharmacokinetics or pharmacodynamics of warfarin. Chest 2006;130:256S.
    • (2006) Chest , vol.130
    • Gerber, M.J.1    Dufton, C.2    Pentikis, H.3
  • 183
    • 0025215525 scopus 로고
    • Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors
    • Beavo JA, Reifsnyder DH. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol Sci 1990;11:150-5.
    • (1990) Trends Pharmacol Sci , vol.11 , pp. 150-155
    • Beavo, J.A.1    Reifsnyder, D.H.2
  • 184
    • 0026327575 scopus 로고    scopus 로고
    • Ahn HS, Foster M, Cable M, Pitts BJ, Sybertz EJ. Ca/CaM-stimulated and cGMP-specific phosphodiesterases in vascular and nonvascular tissues. Adv Exp Med Biol 1991;308:191-7.
    • Ahn HS, Foster M, Cable M, Pitts BJ, Sybertz EJ. Ca/CaM-stimulated and cGMP-specific phosphodiesterases in vascular and nonvascular tissues. Adv Exp Med Biol 1991;308:191-7.
  • 187
    • 0027406998 scopus 로고
    • M and B 22948, a cGMP phosphodiesterase inhibitor, is a pulmonary vasodilator in lambs
    • Braner DA, Fineman JR, Chang R, Soifer SJ. M and B 22948, a cGMP phosphodiesterase inhibitor, is a pulmonary vasodilator in lambs. Am J Physiol 1993;264:H252-8.
    • (1993) Am J Physiol , vol.264
    • Braner, D.A.1    Fineman, J.R.2    Chang, R.3    Soifer, S.J.4
  • 188
    • 0027167474 scopus 로고
    • Influence of Zaprinast on vascular tone and vasodilator responses in the cat pulmonary vascular bed
    • McMahon TJ, Ignarro LJ, Kadowitz PJ. Influence of Zaprinast on vascular tone and vasodilator responses in the cat pulmonary vascular bed. J Appl Physiol 1993;74:1704-11.
    • (1993) J Appl Physiol , vol.74 , pp. 1704-1711
    • McMahon, T.J.1    Ignarro, L.J.2    Kadowitz, P.J.3
  • 189
    • 0028332080 scopus 로고
    • The type III phosphodiesterase inhibitor milrinone and type V PDE inhibitor dipyridamole individually and synergistically reduce elevated pulmonary vascular resistance
    • Clarke WR, Uezono S, Chambers A, Doepfner P. The type III phosphodiesterase inhibitor milrinone and type V PDE inhibitor dipyridamole individually and synergistically reduce elevated pulmonary vascular resistance. Pulm Pharmacol 1994;7:81-9.
    • (1994) Pulm Pharmacol , vol.7 , pp. 81-89
    • Clarke, W.R.1    Uezono, S.2    Chambers, A.3    Doepfner, P.4
  • 190
    • 0030070656 scopus 로고    scopus 로고
    • Inhibition of cyclic 3′-5′-guanosine monophosphate-specific phosphodiesterase selectively vasodilates the pulmonary circulation in chronically hypoxic rats
    • Cohen AH, Hanson K, Morris K, Fouty B, McMurty IF, Clarke W, et al. Inhibition of cyclic 3′-5′-guanosine monophosphate-specific phosphodiesterase selectively vasodilates the pulmonary circulation in chronically hypoxic rats. J Clin Invest 1996;97:172-9.
    • (1996) J Clin Invest , vol.97 , pp. 172-179
    • Cohen, A.H.1    Hanson, K.2    Morris, K.3    Fouty, B.4    McMurty, I.F.5    Clarke, W.6
  • 192
    • 0028808770 scopus 로고    scopus 로고
    • rd, Russell JA, Steinhorn RH. The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide. Am J Respir Crit Care Med 1995;152:1605-10.
    • rd, Russell JA, Steinhorn RH. The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide. Am J Respir Crit Care Med 1995;152:1605-10.
  • 193
    • 0031979704 scopus 로고    scopus 로고
    • Dipyridamole potentiates pulmonary vasodilation induced by acetylcholine and nitric oxide in the ovine fetus
    • Ziegler JW, Ivy DD, Fox JJ, Kinsella JP, Clarke WR, Abman SH. Dipyridamole potentiates pulmonary vasodilation induced by acetylcholine and nitric oxide in the ovine fetus. Am J Respir Crit Care Med 1998;157:1104-10.
    • (1998) Am J Respir Crit Care Med , vol.157 , pp. 1104-1110
    • Ziegler, J.W.1    Ivy, D.D.2    Fox, J.J.3    Kinsella, J.P.4    Clarke, W.R.5    Abman, S.H.6
  • 194
    • 33746584053 scopus 로고    scopus 로고
    • Sildenafil: From angina to erectile dysfunction to pulmonary hypertension and beyond
    • Ghofrani HA, Osterloh IH, Grimminger F. Sildenafil: From angina to erectile dysfunction to pulmonary hypertension and beyond. Nat Rev Drug Discov 2006;5:689-702.
    • (2006) Nat Rev Drug Discov , vol.5 , pp. 689-702
    • Ghofrani, H.A.1    Osterloh, I.H.2    Grimminger, F.3
  • 195
    • 0034597646 scopus 로고    scopus 로고
    • Prasad S, Wilkinson J, Gatzoulis MA. Sildenafil in primary pulmonary hypertension. N Engl J Med 2000;343:1342.
    • Prasad S, Wilkinson J, Gatzoulis MA. Sildenafil in primary pulmonary hypertension. N Engl J Med 2000;343:1342.
  • 196
    • 0141482069 scopus 로고    scopus 로고
    • Immediate and long-term hemodynamic and clinical effects of sildenafil in patients with pulmonary arterial hypertension receiving vasodilator therapy
    • Bhatia S, Frantz RP, Severson CJ, Durst LA, McGoon MD. Immediate and long-term hemodynamic and clinical effects of sildenafil in patients with pulmonary arterial hypertension receiving vasodilator therapy. Mayo Clin Proc 2003;78:1207-13.
    • (2003) Mayo Clin Proc , vol.78 , pp. 1207-1213
    • Bhatia, S.1    Frantz, R.P.2    Severson, C.J.3    Durst, L.A.4    McGoon, M.D.5
  • 197
    • 0242349756 scopus 로고    scopus 로고
    • Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension
    • Michelakis ED, Tymchak W, Noga M, Webster L, Wu XC, Lien D, et al. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension. Circulation 2003;108:2066-9.
    • (2003) Circulation , vol.108 , pp. 2066-2069
    • Michelakis, E.D.1    Tymchak, W.2    Noga, M.3    Webster, L.4    Wu, X.C.5    Lien, D.6
  • 199
    • 0037152092 scopus 로고    scopus 로고
    • Sildenafil for treatment of lung fibrosis and pulmonary hypertension: A randomised controlled trial
    • Ghofrani HA, Wiedemann R, Rose F, Schermuly RT, Olschewski H, Weissmann N, et al. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: A randomised controlled trial. Lancet 2002;360:895-900.
    • (2002) Lancet , vol.360 , pp. 895-900
    • Ghofrani, H.A.1    Wiedemann, R.2    Rose, F.3    Schermuly, R.T.4    Olschewski, H.5    Weissmann, N.6
  • 200
    • 1842530387 scopus 로고    scopus 로고
    • Clinical efficacy of sildenafil in primary pulmonary hypertension: A randomized, placebo-controlled, double-blind, crossover study
    • Sastry BK, Narasimhan C, Reddy NK, Raju BS. Clinical efficacy of sildenafil in primary pulmonary hypertension: A randomized, placebo-controlled, double-blind, crossover study. J Am Coll Cardiol 2004;43:1149-53.
    • (2004) J Am Coll Cardiol , vol.43 , pp. 1149-1153
    • Sastry, B.K.1    Narasimhan, C.2    Reddy, N.K.3    Raju, B.S.4
  • 202
    • 34548215143 scopus 로고    scopus 로고
    • Effect of sildenafil on ventilatory efficiency and exercise tolerance in pulmonary hypertension
    • Oudiz RJ, Roveran G, Hansen JE, Sun XG, Wasserman K. Effect of sildenafil on ventilatory efficiency and exercise tolerance in pulmonary hypertension. Eur J Heart Fail 2007;9:917-21.
    • (2007) Eur J Heart Fail , vol.9 , pp. 917-921
    • Oudiz, R.J.1    Roveran, G.2    Hansen, J.E.3    Sun, X.G.4    Wasserman, K.5
  • 203
    • 0037150158 scopus 로고    scopus 로고
    • Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension comparison with inhaled nitric oxide
    • Michelakis E, Tymchak W, Lien D, Webster L, Hashimoto K, Archer S. Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension comparison with inhaled nitric oxide. Circulation 2002;105: 2398-403.
    • (2002) Circulation , vol.105 , pp. 2398-2403
    • Michelakis, E.1    Tymchak, W.2    Lien, D.3    Webster, L.4    Hashimoto, K.5    Archer, S.6
  • 206
    • 33646489801 scopus 로고    scopus 로고
    • Nonarteritic anterior ischemic optic neuropathy and sildenafil
    • Fraunfelder FW, Pomeranz HD, Egan RA. Nonarteritic anterior ischemic optic neuropathy and sildenafil. Arch Ophthalmol 2006;124:733-4.
    • (2006) Arch Ophthalmol , vol.124 , pp. 733-734
    • Fraunfelder, F.W.1    Pomeranz, H.D.2    Egan, R.A.3
  • 207
    • 0028041139 scopus 로고
    • Arginine deficiency accompanies persistent pulmonary hypertension of the newborn
    • Vosatka RJ, Kashyap S, Trifiletti RR. Arginine deficiency accompanies persistent pulmonary hypertension of the newborn. Biol Neonate 1994;66:65-70.
    • (1994) Biol Neonate , vol.66 , pp. 65-70
    • Vosatka, R.J.1    Kashyap, S.2    Trifiletti, R.R.3
  • 208
    • 0029015149 scopus 로고
    • Effect of L-arginine infusion on infants with persistent pulmonary hypertension of the newborn
    • McCaffrey MJ, Bose CL, Reiter PD, Stiles AD. Effect of L-arginine infusion on infants with persistent pulmonary hypertension of the newborn. Biol Neonate 1995;67:240-3.
    • (1995) Biol Neonate , vol.67 , pp. 240-243
    • McCaffrey, M.J.1    Bose, C.L.2    Reiter, P.D.3    Stiles, A.D.4
  • 209
    • 0030840893 scopus 로고    scopus 로고
    • Prolonged administration of L-arginine ameliorates chronic pulmonary hypertension and pulmonary vascular remodeling in rats
    • Mitani Y, Maruyama K, Sakurai M. Prolonged administration of L-arginine ameliorates chronic pulmonary hypertension and pulmonary vascular remodeling in rats. Circulation 1997;96: 689-97.
    • (1997) Circulation , vol.96 , pp. 689-697
    • Mitani, Y.1    Maruyama, K.2    Sakurai, M.3
  • 210
    • 0029083303 scopus 로고
    • Short-term pulmonary vasodilation with L-arginine in pulmonary hypertension
    • Mehta S, Stewart DJ, Langleben D, Levy RD. Short-term pulmonary vasodilation with L-arginine in pulmonary hypertension. Circulation 1995;92:1539-45.
    • (1995) Circulation , vol.92 , pp. 1539-1545
    • Mehta, S.1    Stewart, D.J.2    Langleben, D.3    Levy, R.D.4
  • 211
    • 0035060156 scopus 로고    scopus 로고
    • Short-term oral administration of L-arginine improves hemodynamics and exercise capacity in patients with precapillary pulmonary hypertension
    • Nagaya N, Uematsu M, Oya H, Sato N, Sakamaki F, Kyotani S, et al. Short-term oral administration of L-arginine improves hemodynamics and exercise capacity in patients with precapillary pulmonary hypertension. Am J Respir Crit Care Med 2001;163: 887-91.
    • (2001) Am J Respir Crit Care Med , vol.163 , pp. 887-891
    • Nagaya, N.1    Uematsu, M.2    Oya, H.3    Sato, N.4    Sakamaki, F.5    Kyotani, S.6
  • 213
    • 0027236094 scopus 로고
    • L-arginine infusion has no effect on systemic hemodynamics in normal volunteers or systemic and pulmonary hemodynamics in patients with elevated pulmonary vascular resistance
    • Baudouin SV, Bath P, Martin JF, Du Bois R, Evans TW. L-arginine infusion has no effect on systemic hemodynamics in normal volunteers or systemic and pulmonary hemodynamics in patients with elevated pulmonary vascular resistance. Br J Clin Pharmacol 1993;36:45-9.
    • (1993) Br J Clin Pharmacol , vol.36 , pp. 45-49
    • Baudouin, S.V.1    Bath, P.2    Martin, J.F.3    Du Bois, R.4    Evans, T.W.5
  • 215
    • 4544302647 scopus 로고    scopus 로고
    • Combination therapy for pulmonary arterial hypertension: Still more questions than answers
    • Hoeper MM, Dinh-Xuan AT. Combination therapy for pulmonary arterial hypertension: Still more questions than answers. Eur Respir J 2004;24:339-40.
    • (2004) Eur Respir J , vol.24 , pp. 339-340
    • Hoeper, M.M.1    Dinh-Xuan, A.T.2
  • 217
    • 23744496842 scopus 로고    scopus 로고
    • Bosentan improves exercise tolerance and Tei index in patients with pulmonary hypertension and prostanoid therapy
    • Seyfarth HJ, Pankau H, Hammerschmidt S, Schauer J, Wirtz H, Winkler J. Bosentan improves exercise tolerance and Tei index in patients with pulmonary hypertension and prostanoid therapy. Chest 2005;128:709-13.
    • (2005) Chest , vol.128 , pp. 709-713
    • Seyfarth, H.J.1    Pankau, H.2    Hammerschmidt, S.3    Schauer, J.4    Wirtz, H.5    Winkler, J.6
  • 218
    • 33748931278 scopus 로고    scopus 로고
    • Safety and efficacy of inhaled treprostinil as add on therapy to bosentan in pulmonary arterial hypertension
    • Channick RN, Olschewski H, Seeger W, Staub T, Voswinckel R, Rubin LJ. Safety and efficacy of inhaled treprostinil as add on therapy to bosentan in pulmonary arterial hypertension. J Am Coll Cardiol 2006;48:1433-7.
    • (2006) J Am Coll Cardiol , vol.48 , pp. 1433-1437
    • Channick, R.N.1    Olschewski, H.2    Seeger, W.3    Staub, T.4    Voswinckel, R.5    Rubin, L.J.6
  • 219
    • 0032031727 scopus 로고    scopus 로고
    • Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension
    • Lee SD, Shroyer KR, Markham NE, Cool CD, Voelkel NF, Tuder RM. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J Clin Invest 1998;101:927-34.
    • (1998) J Clin Invest , vol.101 , pp. 927-934
    • Lee, S.D.1    Shroyer, K.R.2    Markham, N.E.3    Cool, C.D.4    Voelkel, N.F.5    Tuder, R.M.6
  • 220
    • 0037868048 scopus 로고    scopus 로고
    • Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension
    • Ghofrani HA, Rose F, Schermuly RT, Olschewski H, Wiedemann R, Kreckel A, et al. Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension. J Am Coll Cardiol 2003;42:158-64.
    • (2003) J Am Coll Cardiol , vol.42 , pp. 158-164
    • Ghofrani, H.A.1    Rose, F.2    Schermuly, R.T.3    Olschewski, H.4    Wiedemann, R.5    Kreckel, A.6
  • 221
    • 0035845634 scopus 로고    scopus 로고
    • Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension
    • Wilkens H, Guth A, Konig J, Forestier N, Cremers B, Hennen B, et al. Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension. Circulation 2001;104:1218-22.
    • (2001) Circulation , vol.104 , pp. 1218-1222
    • Wilkens, H.1    Guth, A.2    Konig, J.3    Forestier, N.4    Cremers, B.5    Hennen, B.6
  • 223
    • 0031036533 scopus 로고    scopus 로고
    • Hyperdynamic circulation in patients with cirrhosis: Direct measurement of nitric oxide levels in hepatic and portal veins
    • Battista S, Bar F, Mengozzi G, Zanon E, Grosso M, Molino G. Hyperdynamic circulation in patients with cirrhosis: Direct measurement of nitric oxide levels in hepatic and portal veins. J Hepatol 1997;26:75-80.
    • (1997) J Hepatol , vol.26 , pp. 75-80
    • Battista, S.1    Bar, F.2    Mengozzi, G.3    Zanon, E.4    Grosso, M.5    Molino, G.6
  • 225
    • 21744438514 scopus 로고    scopus 로고
    • Bosentan decreases the plasma concentration of sildenafil when co-prescribed in pulmonary hypertension
    • Paul GA, Gibbs JS, Boobis AR, Abbas A, Wilkins MR. Bosentan decreases the plasma concentration of sildenafil when co-prescribed in pulmonary hypertension. Br J Clin Pharmacol 2005;60:107-12.
    • (2005) Br J Clin Pharmacol , vol.60 , pp. 107-112
    • Paul, G.A.1    Gibbs, J.S.2    Boobis, A.R.3    Abbas, A.4    Wilkins, M.R.5
  • 226
    • 1342288852 scopus 로고    scopus 로고
    • Clinical value of vasodilator test with inhaled nitric oxide for predicting longterm response top oral vasodilators in pulmonary hypertension
    • Morales J, Santos S, de Jover L, Sala E, Paré C, Roca J, et al. Clinical value of vasodilator test with inhaled nitric oxide for predicting longterm response top oral vasodilators in pulmonary hypertension. Respir Med 2004;98:225-34.
    • (2004) Respir Med , vol.98 , pp. 225-234
    • Morales, J.1    Santos, S.2    de Jover, L.3    Sala, E.4    Paré, C.5    Roca, J.6
  • 227
    • 20244386797 scopus 로고    scopus 로고
    • Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension
    • Langleben D, Christman BW, Barst RJ, Dias VC, Galiè N, Higenbottam TW, et al. Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension. Am Heart J 2002;143:E4.
    • (2002) Am Heart J , vol.143
    • Langleben, D.1    Christman, B.W.2    Barst, R.J.3    Dias, V.C.4    Galiè, N.5    Higenbottam, T.W.6
  • 228
    • 0032882581 scopus 로고    scopus 로고
    • Inhaled nitric oxide reduces pulmonary artery pressures in portopulmonary hypertension
    • Findlay JF, Harrison BA, Plevak DJ, Krowka MJ. Inhaled nitric oxide reduces pulmonary artery pressures in portopulmonary hypertension. Liver Transpl 1999;5:381-7.
    • (1999) Liver Transpl , vol.5 , pp. 381-387
    • Findlay, J.F.1    Harrison, B.A.2    Plevak, D.J.3    Krowka, M.J.4
  • 229
    • 0001645937 scopus 로고
    • Experimental studies of the surgical treatment of primary pulmonary hypertension
    • Austen WG, Morrow AG, Berry WB. Experimental studies of the surgical treatment of primary pulmonary hypertension. J Thorac Cardiovasc Surg 1964;48:448-55.
    • (1964) J Thorac Cardiovasc Surg , vol.48 , pp. 448-455
    • Austen, W.G.1    Morrow, A.G.2    Berry, W.B.3
  • 230
    • 0022617998 scopus 로고
    • Factors that influence the outcome of primary pulmonary hypertension
    • Rozkovec A, Montanes P, Oakley CM. Factors that influence the outcome of primary pulmonary hypertension. Br Heart J 1986;55:449-58.
    • (1986) Br Heart J , vol.55 , pp. 449-458
    • Rozkovec, A.1    Montanes, P.2    Oakley, C.M.3
  • 231
    • 0034817271 scopus 로고    scopus 로고
    • Atrial septostomy for pulmonary hypertension
    • Sandoval J, Rothman A, Pulido T. Atrial septostomy for pulmonary hypertension. Clin Chest Med 2001;22:547-60.
    • (2001) Clin Chest Med , vol.22 , pp. 547-560
    • Sandoval, J.1    Rothman, A.2    Pulido, T.3
  • 233
    • 0025999492 scopus 로고
    • Effects of atrial septostomy in patients with terminal cor pulmonale due to pulmonary vascular disease
    • Nihill MR, O'Laughlin MP, Mullins CE. Effects of atrial septostomy in patients with terminal cor pulmonale due to pulmonary vascular disease. Cathet Cardiovasc Diagn 1991;24:166-72.
    • (1991) Cathet Cardiovasc Diagn , vol.24 , pp. 166-172
    • Nihill, M.R.1    O'Laughlin, M.P.2    Mullins, C.E.3
  • 234
    • 0036490437 scopus 로고    scopus 로고
    • Graded balloon atrial septostomy in severe pulmonary hypertension
    • Kothari SS, Yusuf A, Juneja R, Yadav R, Naik N. Graded balloon atrial septostomy in severe pulmonary hypertension. Indian Heart J 2002;54:164-9.
    • (2002) Indian Heart J , vol.54 , pp. 164-169
    • Kothari, S.S.1    Yusuf, A.2    Juneja, R.3    Yadav, R.4    Naik, N.5
  • 235
    • 0028915973 scopus 로고
    • Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension
    • Kerstein D, Levy P, Hsu DT, Hordof AJ, Gersony WM, Barst RJ. Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension. Circulation 1995;91:2028-35.
    • (1995) Circulation , vol.91 , pp. 2028-2035
    • Kerstein, D.1    Levy, P.2    Hsu, D.T.3    Hordof, A.J.4    Gersony, W.M.5    Barst, R.J.6
  • 237
    • 34247171239 scopus 로고    scopus 로고
    • Atrial septostomy improves survival in select patients with pulmonary hypertension
    • Law MA, Grifka RG, Mullins CE, Nihill MR. Atrial septostomy improves survival in select patients with pulmonary hypertension. Am Heart J 2007;153:779-84.
    • (2007) Am Heart J , vol.153 , pp. 779-784
    • Law, M.A.1    Grifka, R.G.2    Mullins, C.E.3    Nihill, M.R.4
  • 238
    • 0035070836 scopus 로고    scopus 로고
    • Balloon atrial septostomy in end-stage pulmonary hypertension guided a novel intracarduiac echocardiographic transducer
    • Moscucci M, Dairywala IT, Chetcuti S, Mathew B, Li P, Rubenfire M, et al. Balloon atrial septostomy in end-stage pulmonary hypertension guided a novel intracarduiac echocardiographic transducer. Catheter Cardiovasc Interv 2001;52:530-4.
    • (2001) Catheter Cardiovasc Interv , vol.52 , pp. 530-534
    • Moscucci, M.1    Dairywala, I.T.2    Chetcuti, S.3    Mathew, B.4    Li, P.5    Rubenfire, M.6
  • 244
    • 0029862649 scopus 로고    scopus 로고
    • Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation: Early risk factors
    • Sharples LD, Tamm M, McNeil K, Higenbottam TW, Stewart S, Wallwork J. Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation: Early risk factors. Transplantation 1996;61:560-6.
    • (1996) Transplantation , vol.61 , pp. 560-566
    • Sharples, L.D.1    Tamm, M.2    McNeil, K.3    Higenbottam, T.W.4    Stewart, S.5    Wallwork, J.6
  • 246
    • 0027398136 scopus 로고
    • Second natural history study of congenital heart defects: Results of treatment of patients with ventricular septal defects
    • Kidd L, Driscoll DJ, Gersony WM, Hayes CJ, Keane JF, O'Fallon WM, et al. Second natural history study of congenital heart defects: Results of treatment of patients with ventricular septal defects. Circulation 1993;87:I38-51.
    • (1993) Circulation , vol.87
    • Kidd, L.1    Driscoll, D.J.2    Gersony, W.M.3    Hayes, C.J.4    Keane, J.F.5    O'Fallon, W.M.6
  • 247
    • 0010468355 scopus 로고
    • Atrial septal defects with pulmonary hypertension
    • Besterman E. Atrial septal defects with pulmonary hypertension. Br Heart J 1961;23:587-98.
    • (1961) Br Heart J , vol.23 , pp. 587-598
    • Besterman, E.1
  • 248
    • 0013813476 scopus 로고
    • The natural history of ventricular septal defects in infancy
    • Hoffman JE, Rudolph AM. The natural history of ventricular septal defects in infancy. Am J Cardiol 1985;16:634-53.
    • (1985) Am J Cardiol , vol.16 , pp. 634-653
    • Hoffman, J.E.1    Rudolph, A.M.2
  • 249
    • 0033032078 scopus 로고    scopus 로고
    • Incidence of secondary pulmonary hypertension in adults with atrial septal or sinus venosus defects
    • Vogel M, Berger F, Kramer A, Alexi-Meshkishvili V, Lange PE. Incidence of secondary pulmonary hypertension in adults with atrial septal or sinus venosus defects. Heart 1999;82:30-3.
    • (1999) Heart , vol.82 , pp. 30-33
    • Vogel, M.1    Berger, F.2    Kramer, A.3    Alexi-Meshkishvili, V.4    Lange, P.E.5
  • 250
    • 0032189421 scopus 로고
    • Small ventricular septal defects in adults
    • Neumayer U, Stone S, Somerville J. Small ventricular septal defects in adults. Eur Heart J 1988;19:1573-82.
    • (1988) Eur Heart J , vol.19 , pp. 1573-1582
    • Neumayer, U.1    Stone, S.2    Somerville, J.3
  • 251
  • 252
    • 33745949142 scopus 로고    scopus 로고
    • Abnormal ventilatory response to exercise in adults with congenital heart disease relates to cyanosis and predicts survival
    • Dimopoulos K, Okonko DO, Diller GP, Broberg CS, Salukhe TV, Babu-Narayan SV, et al. Abnormal ventilatory response to exercise in adults with congenital heart disease relates to cyanosis and predicts survival. Circulation 2006;113:2796-802.
    • (2006) Circulation , vol.113 , pp. 2796-2802
    • Dimopoulos, K.1    Okonko, D.O.2    Diller, G.P.3    Broberg, C.S.4    Salukhe, T.V.5    Babu-Narayan, S.V.6
  • 253
    • 0030245602 scopus 로고    scopus 로고
    • Cerebrovascular events in adult patients with cyanotic congenital heart disease
    • Ammash N, Warnes CA. Cerebrovascular events in adult patients with cyanotic congenital heart disease. J Am Coll Cardiol 1996;28:768-72.
    • (1996) J Am Coll Cardiol , vol.28 , pp. 768-772
    • Ammash, N.1    Warnes, C.A.2
  • 254
    • 0038306324 scopus 로고    scopus 로고
    • Proximal pulmonary arterial and intrapulmonary radiologic features of Eisenmenger syndrome and primary pulmonary hypertension
    • Perloff JK, Hart EM, Greaves SM, Miner PD, Child JS. Proximal pulmonary arterial and intrapulmonary radiologic features of Eisenmenger syndrome and primary pulmonary hypertension. Am J Cardiol 2003;92:182-7.
    • (2003) Am J Cardiol , vol.92 , pp. 182-187
    • Perloff, J.K.1    Hart, E.M.2    Greaves, S.M.3    Miner, P.D.4    Child, J.S.5
  • 256
    • 40949099367 scopus 로고    scopus 로고
    • Pulmonary arterial thrombosis in Eisenmenger syndrome is associated with ventricular dysfunction, neurohormonal activation and poorer exercise capacity
    • Broberg C, Ujita M, Bouzas B. Pulmonary arterial thrombosis in Eisenmenger syndrome is associated with ventricular dysfunction, neurohormonal activation and poorer exercise capacity. Circulation 2004;110:497.
    • (2004) Circulation , vol.110 , pp. 497
    • Broberg, C.1    Ujita, M.2    Bouzas, B.3
  • 257
    • 34547577592 scopus 로고    scopus 로고
    • Pulmonary arterial thrombosis in eisenmenger syndrome is associated with biventricular dysfunction and decreased pulmonary flow velocity
    • Broberg CS, Ujita M, Prasad S, Li W, Rubens M, Bax BE, et al. Pulmonary arterial thrombosis in eisenmenger syndrome is associated with biventricular dysfunction and decreased pulmonary flow velocity. J Am Coll Cardiol 2007;50:634-42.
    • (2007) J Am Coll Cardiol , vol.50 , pp. 634-642
    • Broberg, C.S.1    Ujita, M.2    Prasad, S.3    Li, W.4    Rubens, M.5    Bax, B.E.6
  • 258
    • 0030041787 scopus 로고    scopus 로고
    • Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome
    • Hopkins WE, Ochoa LL, Richardson GW, Trulock EP. Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. J Heart Lung Transplant 1996;15:100-5.
    • (1996) J Heart Lung Transplant , vol.15 , pp. 100-105
    • Hopkins, W.E.1    Ochoa, L.L.2    Richardson, G.W.3    Trulock, E.P.4
  • 259
    • 33745792342 scopus 로고    scopus 로고
    • Presentation, survival prospects and predictors of death in Eisenmenger syndrome: A combined retrospective and case-control study
    • Diller GP, Dimopoulos K, Broberg GS, Kaya MG, Naghotra US, Uebing A, et al. Presentation, survival prospects and predictors of death in Eisenmenger syndrome: A combined retrospective and case-control study. Eur Heart J 2006;27:1737-42.
    • (2006) Eur Heart J , vol.27 , pp. 1737-1742
    • Diller, G.P.1    Dimopoulos, K.2    Broberg, G.S.3    Kaya, M.G.4    Naghotra, U.S.5    Uebing, A.6
  • 260
    • 4444294201 scopus 로고    scopus 로고
    • Responsiveness to inhaled nitric oxide is a predictor for mid-term survival in adult patients with congenital heart defects and pulmonary arterial hypertension
    • Post MC, Janssens S, Van de Werf F, Budts W. Responsiveness to inhaled nitric oxide is a predictor for mid-term survival in adult patients with congenital heart defects and pulmonary arterial hypertension. Eur Heart J 2004;25:1651-6.
    • (2004) Eur Heart J , vol.25 , pp. 1651-1656
    • Post, M.C.1    Janssens, S.2    Van de Werf, F.3    Budts, W.4
  • 261
    • 0036710067 scopus 로고    scopus 로고
    • Eisenmenger's syndrome: Current management
    • Berman EB, Barst RJ. Eisenmenger's syndrome: Current management. Prog Cardiovasc Dis 2002;45:129-38.
    • (2002) Prog Cardiovasc Dis , vol.45 , pp. 129-138
    • Berman, E.B.1    Barst, R.J.2
  • 262
    • 0034598755 scopus 로고    scopus 로고
    • Congenital heart disease in adults: Second of two parts
    • Brickner ME, Hillis LD, Lange RA. Congenital heart disease in adults: Second of two parts. N Engl J Med 2000;342:334-42.
    • (2000) N Engl J Med , vol.342 , pp. 334-342
    • Brickner, M.E.1    Hillis, L.D.2    Lange, R.A.3
  • 263
    • 0032744430 scopus 로고    scopus 로고
    • Continuous intravenous epoprostenol therapy for pulmonary hypertension in Gaucher.s disease
    • Bakst AE, Gaine SP, Rubin LJ. Continuous intravenous epoprostenol therapy for pulmonary hypertension in Gaucher.s disease. Chest 1999;116:1127-9.
    • (1999) Chest , vol.116 , pp. 1127-1129
    • Bakst, A.E.1    Gaine, S.P.2    Rubin, L.J.3
  • 264
    • 0036013752 scopus 로고    scopus 로고
    • Transitioning from IV epoprostenol to subcutaneous treprostinil in pulmonary arterial hypertension
    • Vachiery JL, Hill N, Zwicke D, Barst R, Blackburn S, Naeije R. Transitioning from IV epoprostenol to subcutaneous treprostinil in pulmonary arterial hypertension. Chest 2002;121:1561-5.
    • (2002) Chest , vol.121 , pp. 1561-1565
    • Vachiery, J.L.1    Hill, N.2    Zwicke, D.3    Barst, R.4    Blackburn, S.5    Naeije, R.6
  • 265
    • 0025977116 scopus 로고
    • Pulmonary hypertension complicating portal hypertension: Prevalence and relation to splanchnic hemodynamics
    • Hadengue A, Benhayoun MK, Lebrec D, Benhamou JP. Pulmonary hypertension complicating portal hypertension: Prevalence and relation to splanchnic hemodynamics. Gastroenterology 1991;100:520-8.
    • (1991) Gastroenterology , vol.100 , pp. 520-528
    • Hadengue, A.1    Benhayoun, M.K.2    Lebrec, D.3    Benhamou, J.P.4
  • 267
    • 2342453333 scopus 로고    scopus 로고
    • Portopulmonary hypertension and hepatopulmonary syndrome
    • Hoeper MM, Krowka MJ, Strassburg CP. Portopulmonary hypertension and hepatopulmonary syndrome. Lancet 2004;363: 1461-8.
    • (2004) Lancet , vol.363 , pp. 1461-1468
    • Hoeper, M.M.1    Krowka, M.J.2    Strassburg, C.P.3
  • 268
    • 0020640953 scopus 로고
    • Primary pulmonary hypertension and cirrhosis: Are they related
    • McDonnell PJ, Toye PA, Hutchins GM. Primary pulmonary hypertension and cirrhosis: are they related. Am Rev Respir Dis 1983;127:437-41.
    • (1983) Am Rev Respir Dis , vol.127 , pp. 437-441
    • McDonnell, P.J.1    Toye, P.A.2    Hutchins, G.M.3
  • 269
    • 0029875388 scopus 로고    scopus 로고
    • Pulmonary hypertension in chronic liver diseases
    • Mandell MS, Groves BM. Pulmonary hypertension in chronic liver diseases. Clin Chest Med 1996;17:17-33.
    • (1996) Clin Chest Med , vol.17 , pp. 17-33
    • Mandell, M.S.1    Groves, B.M.2
  • 271
    • 0037332028 scopus 로고    scopus 로고
    • Portopulmonary hypertension: A tale of two circulations
    • Budhiraja R, Hassoun PM. Portopulmonary hypertension: A tale of two circulations. Chest 2003;123:562-76.
    • (2003) Chest , vol.123 , pp. 562-576
    • Budhiraja, R.1    Hassoun, P.M.2
  • 272
    • 0030317077 scopus 로고    scopus 로고
    • Frequency and clinical implications of increased pulmonary artery pressures in liver transplantation
    • Castro M, Krowka MJ, Schroeder DR, Beck KC, Plevak DJ, Rettke SR, et al. Frequency and clinical implications of increased pulmonary artery pressures in liver transplantation. Mayo Clin Proc 1996;71:543-51.
    • (1996) Mayo Clin Proc , vol.71 , pp. 543-551
    • Castro, M.1    Krowka, M.J.2    Schroeder, D.R.3    Beck, K.C.4    Plevak, D.J.5    Rettke, S.R.6
  • 274
    • 0027210789 scopus 로고
    • Successful liver transplantation in patients with mild to moderate pulmonary hypertension
    • Plevak D, Krowka MJ, Rettke S, Dunn W, Southorn P. Successful liver transplantation in patients with mild to moderate pulmonary hypertension. Transplant Proc 1993;25:1840.
    • (1993) Transplant Proc , vol.25 , pp. 1840
    • Plevak, D.1    Krowka, M.J.2    Rettke, S.3    Dunn, W.4    Southorn, P.5
  • 276
    • 10744233940 scopus 로고    scopus 로고
    • Pulmonary hypertension as a risk factor for death in patients with sickle cell disease
    • Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 2004;350:886-95.
    • (2004) N Engl J Med , vol.350 , pp. 886-895
    • Gladwin, M.T.1    Sachdev, V.2    Jison, M.L.3    Shizukuda, Y.4    Plehn, J.F.5    Minter, K.6
  • 277
    • 20044376234 scopus 로고    scopus 로고
    • The relationship of pulmonary hypertension and survival in sickle cell disease
    • Ataga K, Jones S, Olajide O, Strayhorn D, Lail A, Orringer EP. The relationship of pulmonary hypertension and survival in sickle cell disease. Blood 2004b;104:463a.
    • (2004) Blood , vol.104
    • Ataga, K.1    Jones, S.2    Olajide, O.3    Strayhorn, D.4    Lail, A.5    Orringer, E.P.6
  • 278
    • 0036802402 scopus 로고    scopus 로고
    • Pulmonary hypertension in sickle cell hemoglobinopathy: A clinicopathologic study of 20 cases
    • Haque AK, Gokhale S, Rampy BA, Adegboyega P, Duarte A, Saldana MJ. Pulmonary hypertension in sickle cell hemoglobinopathy: A clinicopathologic study of 20 cases. Hum Pathol 2002;33:1037-43.
    • (2002) Hum Pathol , vol.33 , pp. 1037-1043
    • Haque, A.K.1    Gokhale, S.2    Rampy, B.A.3    Adegboyega, P.4    Duarte, A.5    Saldana, M.J.6
  • 280
    • 1342289333 scopus 로고    scopus 로고
    • Pulmonary hypertension in sickle cell disease
    • Vichinsky EP. Pulmonary hypertension in sickle cell disease. N Engl J Med 2004;350:857-9.
    • (2004) N Engl J Med , vol.350 , pp. 857-859
    • Vichinsky, E.P.1
  • 281
    • 20044395385 scopus 로고    scopus 로고
    • Pulmonary hypertension in SS, SC and Sβ thalassemia: Prevalence, associated clinical syndromes and mortality
    • Castro LM, Jonassiant JC, Graham FL, Ashley-Koch A, Tellen MJ. Pulmonary hypertension in SS, SC and Sβ thalassemia: Prevalence, associated clinical syndromes and mortality. Blood 2004;104:462a.
    • (2004) Blood , vol.104
    • Castro, L.M.1    Jonassiant, J.C.2    Graham, F.L.3    Ashley-Koch, A.4    Tellen, M.J.5
  • 282
    • 20044386727 scopus 로고    scopus 로고
    • Chronic sickle cell lung disease: New insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension
    • Machado RF, Gladwin MT. Chronic sickle cell lung disease: New insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension. Br J Haematol 2005;129:449-64.
    • (2005) Br J Haematol , vol.129 , pp. 449-464
    • Machado, R.F.1    Gladwin, M.T.2
  • 286
    • 0032189803 scopus 로고    scopus 로고
    • Plasma endothelin-1, cytokine and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis
    • Graido-Gonzalez E, Doherty JC, Bergreen EW, Organ G, Telfer M, McMillen MA. Plasma endothelin-1, cytokine and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis. Blood 1998;92:2551-5.
    • (1998) Blood , vol.92 , pp. 2551-2555
    • Graido-Gonzalez, E.1    Doherty, J.C.2    Bergreen, E.W.3    Organ, G.4    Telfer, M.5    McMillen, M.A.6
  • 288
    • 0142215534 scopus 로고    scopus 로고
    • Investigators of the cooperative study of sickle cell disease: Causes of death in sickle cell disease: An autopsy study
    • Manci EA, Culberson DE, Yang YM, Gardner TM, Powell R, Haynes J Jr, et al. Investigators of the cooperative study of sickle cell disease: Causes of death in sickle cell disease: An autopsy study. Br J Haematol 2003;123:359-65.
    • (2003) Br J Haematol , vol.123 , pp. 359-365
    • Manci, E.A.1    Culberson, D.E.2    Yang, Y.M.3    Gardner, T.M.4    Powell, R.5    Haynes Jr, J.6
  • 292
  • 293
    • 0037414164 scopus 로고    scopus 로고
    • Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: Risks and benefits up to 9 years of treatment
    • Steinberg MH, Barton F, Castro O, Pegelow CH, Ballas SK, Kutlar A, et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: Risks and benefits up to 9 years of treatment. J Am Med Assoc 2003;289:1645-51.
    • (2003) J Am Med Assoc , vol.289 , pp. 1645-1651
    • Steinberg, M.H.1    Barton, F.2    Castro, O.3    Pegelow, C.H.4    Ballas, S.K.5    Kutlar, A.6
  • 294
    • 0029025475 scopus 로고
    • Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia: Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia
    • Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia: Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 1995;332:1317-22.
    • (1995) N Engl J Med , vol.332 , pp. 1317-1322
    • Charache, S.1    Terrin, M.L.2    Moore, R.D.3    Dover, G.J.4    Barton, F.B.5    Eckert, S.V.6
  • 295
    • 0029005136 scopus 로고
    • Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions
    • Pegelow CH, Adams RJ, McKie V, Abboud M, Berman B, Miller ST, et al. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr 1995;126:896-9.
    • (1995) J Pediatr , vol.126 , pp. 896-899
    • Pegelow, C.H.1    Adams, R.J.2    McKie, V.3    Abboud, M.4    Berman, B.5    Miller, S.T.6
  • 296
    • 0032474692 scopus 로고    scopus 로고
    • Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography
    • Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998;339:5-11.
    • (1998) N Engl J Med , vol.339 , pp. 5-11
    • Adams, R.J.1    McKie, V.C.2    Hsu, L.3    Files, B.4    Vichinsky, E.5    Pegelow, C.6
  • 297
    • 0037307055 scopus 로고    scopus 로고
    • Nocturnal oxygen saturation and painful sickle cell crises in children
    • Hargrave DR, Wade A, Evans JP, Hewes DK, Kirkham FJ. Nocturnal oxygen saturation and painful sickle cell crises in children. Blood 2003;101:846-8.
    • (2003) Blood , vol.101 , pp. 846-848
    • Hargrave, D.R.1    Wade, A.2    Evans, J.P.3    Hewes, D.K.4    Kirkham, F.J.5
  • 298
    • 0242266583 scopus 로고    scopus 로고
    • Hypoxaemia in sickle cell disease: Biomarker modulation and relevance to pathophysiology
    • Setty BN, Stuart MJ, Dampier C, Brodecki D, Allen JL. Hypoxaemia in sickle cell disease: Biomarker modulation and relevance to pathophysiology. Lancet 2003;362:1450-5.
    • (2003) Lancet , vol.362 , pp. 1450-1455
    • Setty, B.N.1    Stuart, M.J.2    Dampier, C.3    Brodecki, D.4    Allen, J.L.5
  • 299
    • 0042805260 scopus 로고    scopus 로고
    • Hemolytic anemia-associated pulmonary hypertension of sickle cell disease and the nitric oxide/arginine pathway
    • Jison ML, Gladwin MT. Hemolytic anemia-associated pulmonary hypertension of sickle cell disease and the nitric oxide/arginine pathway. Am J Respir Crit Care Med 2003;168:3-4.
    • (2003) Am J Respir Crit Care Med , vol.168 , pp. 3-4
    • Jison, M.L.1    Gladwin, M.T.2
  • 303
    • 20044368380 scopus 로고    scopus 로고
    • Pulmonary hypertension in sickle cell disease: Cardiopulmonary evaluation and response to chronic phosphodiasterase 5 inhibitor therapy
    • Machado RF, Martyr SE, Anthi A, Kato GJ, Hunter LA, Coles WA, et al. Pulmonary hypertension in sickle cell disease: Cardiopulmonary evaluation and response to chronic phosphodiasterase 5 inhibitor therapy. Blood 2004;104:71.
    • (2004) Blood , vol.104 , pp. 71
    • Machado, R.F.1    Martyr, S.E.2    Anthi, A.3    Kato, G.J.4    Hunter, L.A.5    Coles, W.A.6
  • 304
    • 0037630072 scopus 로고    scopus 로고
    • Obstructive sleep apnea and cardiovascular disease
    • Lattimore JD, Celermajer DS, Wilcox I. Obstructive sleep apnea and cardiovascular disease. J Am Coll Cardio I 2003;41:1429-37.
    • (2003) J Am Coll Cardio , vol.1 , Issue.41 , pp. 1429-1437
    • Lattimore, J.D.1    Celermajer, D.S.2    Wilcox, I.3
  • 307
    • 0029949783 scopus 로고    scopus 로고
    • pulmonary hypertension in the obstructive sleep apnea syndrome: Prevalence, causes and therapeutic consequences
    • Kessler R, Chaouat A, Weitzenblum E, Oswald M, Ehrhart M, Apprill M, et al. pulmonary hypertension in the obstructive sleep apnea syndrome: Prevalence, causes and therapeutic consequences. Eur Respir J 1996;9:787-94.
    • (1996) Eur Respir J , vol.9 , pp. 787-794
    • Kessler, R.1    Chaouat, A.2    Weitzenblum, E.3    Oswald, M.4    Ehrhart, M.5    Apprill, M.6
  • 308
    • 0035685436 scopus 로고    scopus 로고
    • Daytime pulmonary hypertension in patients with obstructive apnea: The effect of continous positive airway pressure on pulmonary hemodynamics
    • Alchanatis M, Tourkohoriti G, Kakouros S, Kosmas E, Podaras S, Jordanoglou JB. Daytime pulmonary hypertension in patients with obstructive apnea: The effect of continous positive airway pressure on pulmonary hemodynamics. Respiration 2001;68:666-72.
    • (2001) Respiration , vol.68 , pp. 666-672
    • Alchanatis, M.1    Tourkohoriti, G.2    Kakouros, S.3    Kosmas, E.4    Podaras, S.5    Jordanoglou, J.B.6
  • 309
    • 0021812749 scopus 로고
    • Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome
    • Bradley TD, Rutherford R, Grossman RF, Lue F, Zamel N, Moldofsky H, et al. Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. Am Rev Respir Dis 1985;131:835-9.
    • (1985) Am Rev Respir Dis , vol.131 , pp. 835-839
    • Bradley, T.D.1    Rutherford, R.2    Grossman, R.F.3    Lue, F.4    Zamel, N.5    Moldofsky, H.6
  • 312
    • 0034821544 scopus 로고    scopus 로고
    • The obesity-hypoventilation syndrome revisited: A prospective study of 34 consecutive cases
    • Kessler R, Chaouat A, Schinkewitch P, Faller M, Casel S, Krieger J, et al. The obesity-hypoventilation syndrome revisited: A prospective study of 34 consecutive cases. Chest 2001;120:369-76.
    • (2001) Chest , vol.120 , pp. 369-376
    • Kessler, R.1    Chaouat, A.2    Schinkewitch, P.3    Faller, M.4    Casel, S.5    Krieger, J.6
  • 313
    • 0036741379 scopus 로고    scopus 로고
    • Acute coronary syndrome in patients with human immunodeficiency virus disease
    • Mehta NJ, Khan IA, Mehta RN, Gowda RM. Acute coronary syndrome in patients with human immunodeficiency virus disease. Angiology 2002;53:545-9.
    • (2002) Angiology , vol.53 , pp. 545-549
    • Mehta, N.J.1    Khan, I.A.2    Mehta, R.N.3    Gowda, R.M.4
  • 315
    • 0031925331 scopus 로고    scopus 로고
    • Platelet-derived growth factor expression in primary pulmonary hypertension: Comparison of HIV seropositive and HIV seronegative patients
    • Humbert M, Monti G, Fartoukh M, Magnan A, Brenot F, Rain B, et al. Platelet-derived growth factor expression in primary pulmonary hypertension: Comparison of HIV seropositive and HIV seronegative patients. Eur Respir J 1998;11:554-9.
    • (1998) Eur Respir J , vol.11 , pp. 554-559
    • Humbert, M.1    Monti, G.2    Fartoukh, M.3    Magnan, A.4    Brenot, F.5    Rain, B.6
  • 317
    • 0011678175 scopus 로고
    • Chronic, massive thrombotic obstruction of the pulmonary arteries: Analysis of four operated cases
    • Moser KM, Houk VN, Jones RC, Hufnagel CC. Chronic, massive thrombotic obstruction of the pulmonary arteries: Analysis of four operated cases. Circulation 1965;32:377-85.
    • (1965) Circulation , vol.32 , pp. 377-385
    • Moser, K.M.1    Houk, V.N.2    Jones, R.C.3    Hufnagel, C.C.4
  • 318
    • 0028282859 scopus 로고
    • Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension
    • Tuder RM, Groves B, Badesch DB, Voelkel NF. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol 1994;144:275-85.
    • (1994) Am J Pathol , vol.144 , pp. 275-285
    • Tuder, R.M.1    Groves, B.2    Badesch, D.B.3    Voelkel, N.F.4
  • 324
    • 0042812971 scopus 로고
    • Calcium channel blockers, testing for primary pulmonary hypertension associated with HIV infection
    • Louis M, Thorens JB, Chevrolet JC. Calcium channel blockers, testing for primary pulmonary hypertension associated with HIV infection. Am Rev Respir Dis 1993;147:536A.
    • (1993) Am Rev Respir Dis , vol.147
    • Louis, M.1    Thorens, J.B.2    Chevrolet, J.C.3
  • 325
    • 1042263812 scopus 로고    scopus 로고
    • Inhaled iloprost is a potent acute pulmonary vasodilator in HIV-related severe pulmonary hypertension
    • Ghofrani HA, Friese G, Discher T, Olschewski H, Schermuly RT, Weissmann N, et al. Inhaled iloprost is a potent acute pulmonary vasodilator in HIV-related severe pulmonary hypertension. Eur Respir J 2004;23:321-6.
    • (2004) Eur Respir J , vol.23 , pp. 321-326
    • Ghofrani, H.A.1    Friese, G.2    Discher, T.3    Olschewski, H.4    Schermuly, R.T.5    Weissmann, N.6
  • 326
    • 9644260901 scopus 로고    scopus 로고
    • Bosentan in pulmonary arterial hypertension associated with HIV infection
    • 563s
    • Sitbon O, Gressin V, Speich R, et al. Bosentan in pulmonary arterial hypertension associated with HIV infection. Eur Respir J 2003;22:563s.
    • (2003) Eur Respir J , vol.22
    • Sitbon, O.1    Gressin, V.2    Speich, R.3
  • 328
    • 2342479992 scopus 로고    scopus 로고
    • Pulmonary arterial hypertension related to HIV infection: Improved hemodynamics and survival associated with antiretroviral therapy
    • Zuber JP, Calmy A, Evison JM, Hasse B, Schiffer V, Wagels T, et al. Pulmonary arterial hypertension related to HIV infection: Improved hemodynamics and survival associated with antiretroviral therapy. Clin Infect Dis 2004;38:1178-85.
    • (2004) Clin Infect Dis , vol.38 , pp. 1178-1185
    • Zuber, J.P.1    Calmy, A.2    Evison, J.M.3    Hasse, B.4    Schiffer, V.5    Wagels, T.6
  • 329
    • 0035712395 scopus 로고    scopus 로고
    • Regression of HIV-associated pulmonary arterial hypertension and long-term survival during antiretroviral therapy
    • Speich R, Jenni R, Opravil M, Jaccard R. Regression of HIV-associated pulmonary arterial hypertension and long-term survival during antiretroviral therapy. Swiss Med Wkly 2001;131:663-5.
    • (2001) Swiss Med Wkly , vol.131 , pp. 663-665
    • Speich, R.1    Jenni, R.2    Opravil, M.3    Jaccard, R.4
  • 331
    • 0142187600 scopus 로고    scopus 로고
    • Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: Application of a registry approach
    • Mukerjee D, St George D, Coleiro B, Knight C, Denton CP, Davar J, et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: Application of a registry approach. Ann Rheum Dis 2003;62:1088-93.
    • (2003) Ann Rheum Dis , vol.62 , pp. 1088-1093
    • Mukerjee, D.1    St George, D.2    Coleiro, B.3    Knight, C.4    Denton, C.P.5    Davar, J.6
  • 332
    • 0343183255 scopus 로고    scopus 로고
    • Primary and secondary pulmonary hypertension in systemic lupus erythematosus
    • Pan TL, Thumboo J, Boey ML. Primary and secondary pulmonary hypertension in systemic lupus erythematosus. Lupus 2000;9:338-42.
    • (2000) Lupus , vol.9 , pp. 338-342
    • Pan, T.L.1    Thumboo, J.2    Boey, M.L.3
  • 333
    • 10744232963 scopus 로고    scopus 로고
    • An extreme consequence of splenectomy in dehydrated hereditary stomatocytosis: Gradual thrombo-embolic pulmonary hypertension and lung-heart transplantation
    • Jais X, Till SJ, Cynober T, Ioos V, Gaecia G, Tchernia G, et al. An extreme consequence of splenectomy in dehydrated hereditary stomatocytosis: Gradual thrombo-embolic pulmonary hypertension and lung-heart transplantation. Hemoglobin 2003;27:139-47.
    • (2003) Hemoglobin , vol.27 , pp. 139-147
    • Jais, X.1    Till, S.J.2    Cynober, T.3    Ioos, V.4    Gaecia, G.5    Tchernia, G.6
  • 334
    • 0036875182 scopus 로고    scopus 로고
    • Pulmonary hypertension associated with connective tissue disease
    • Fagan KA, Badesch DB. Pulmonary hypertension associated with connective tissue disease. Prog Cardiovasc Dis 2002;45:225-34.
    • (2002) Prog Cardiovasc Dis , vol.45 , pp. 225-234
    • Fagan, K.A.1    Badesch, D.B.2
  • 335
    • 0035374603 scopus 로고    scopus 로고
    • Pulmonary hypertension in patients with connective tissue diseases
    • Yoshida S, Katayama M. Pulmonary hypertension in patients with connective tissue diseases. Nippon Rinsho 2001;59:1164-7.
    • (2001) Nippon Rinsho , vol.59 , pp. 1164-1167
    • Yoshida, S.1    Katayama, M.2
  • 337
    • 41949109384 scopus 로고    scopus 로고
    • Humbert M, Chaouat A, Bertocchi M. ItinerAIR-HTAP: A French national prospective registry of pulmonary arterial hypertension. Am J Respir Crit Care Med 2004;169:A169.
    • Humbert M, Chaouat A, Bertocchi M. ItinerAIR-HTAP: A French national prospective registry of pulmonary arterial hypertension. Am J Respir Crit Care Med 2004;169:A169.
  • 338
    • 0030987082 scopus 로고    scopus 로고
    • Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection
    • Cool CD, Kennedy D, Voelkel NF, Tuder RM. Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection. Hum Pathol 1997;28:434-42.
    • (1997) Hum Pathol , vol.28 , pp. 434-442
    • Cool, C.D.1    Kennedy, D.2    Voelkel, N.F.3    Tuder, R.M.4
  • 339
    • 0021213058 scopus 로고
    • Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus
    • Quismorio FP Jr, Sharma O, Koss M, Boylen T, Edmiston AW, Thornton PJ, et al. Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus. Semin Arthritis Rheum 1984;13:349-59.
    • (1984) Semin Arthritis Rheum , vol.13 , pp. 349-359
    • Quismorio Jr, F.P.1    Sharma, O.2    Koss, M.3    Boylen, T.4    Edmiston, A.W.5    Thornton, P.J.6
  • 340
    • 0022595288 scopus 로고
    • Pulmonary hypertension and systemic lupus erythematosus
    • Asherson RA, Oakley CM. Pulmonary hypertension and systemic lupus erythematosus. J Rheumatol 1986;13:1-5.
    • (1986) J Rheumatol , vol.13 , pp. 1-5
    • Asherson, R.A.1    Oakley, C.M.2
  • 341
    • 4244014262 scopus 로고
    • Pulmonary hypertension in patients with connective tissue disease and antibody to nuclear ribonucleoprotein
    • Esther JH, Sharp GC, Agia G. Pulmonary hypertension in patients with connective tissue disease and antibody to nuclear ribonucleoprotein. Arthritis Rheum 1981;24:S105.
    • (1981) Arthritis Rheum , vol.24
    • Esther, J.H.1    Sharp, G.C.2    Agia, G.3
  • 343
    • 0023218388 scopus 로고
    • Mixed connective tissue disease with pulmonary hypertension: A clinical and pathological study
    • Hosoda Y, Suzuki Y, Takano M, Tojo T, Homma M. Mixed connective tissue disease with pulmonary hypertension: A clinical and pathological study. J Rheumatol 1987;14:826-30.
    • (1987) J Rheumatol , vol.14 , pp. 826-830
    • Hosoda, Y.1    Suzuki, Y.2    Takano, M.3    Tojo, T.4    Homma, M.5
  • 344
    • 4143121167 scopus 로고    scopus 로고
    • Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease
    • Oudiz RJ, Schilz RJ, Barst RJ, Galié N, Rich S, Rubin LJ, et al. Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease. Chest 2004;126:420-7.
    • (2004) Chest , vol.126 , pp. 420-427
    • Oudiz, R.J.1    Schilz, R.J.2    Barst, R.J.3    Galié, N.4    Rich, S.5    Rubin, L.J.6
  • 346
    • 10744233940 scopus 로고    scopus 로고
    • Pulmonary hypertension as a risk factor for death in patients with sickle cell disease
    • Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 2004;350:886-95.
    • (2004) N Engl J Med , vol.350 , pp. 886-895
    • Gladwin, M.T.1    Sachdev, V.2    Jison, M.L.3    Shizukuda, Y.4    Plehn, J.F.5    Minter, K.6
  • 347
    • 20044376234 scopus 로고    scopus 로고
    • The relationship of pulmonary hypertension and survival in sickle cell disease
    • Ataga K, Jones S, Olajide O, Strayhorn D, Lail A, Orringer EP. The relationship of pulmonary hypertension and survival in sickle cell disease. Blood 2004b;104:463a.
    • (2004) Blood , vol.104
    • Ataga, K.1    Jones, S.2    Olajide, O.3    Strayhorn, D.4    Lail, A.5    Orringer, E.P.6
  • 348
    • 0036802402 scopus 로고    scopus 로고
    • Pulmonary hypertension in sickle cell hemoglobinopathy: A clinicopathologic study of 20 cases
    • Haque AK, Gokhale S, Rampy BA, Adegboyega P, Duarte A, Saldana MJ. Pulmonary hypertension in sickle cell hemoglobinopathy: A clinicopathologic study of 20 cases. Hum Pathol 2002;33:1037-43.
    • (2002) Hum Pathol , vol.33 , pp. 1037-1043
    • Haque, A.K.1    Gokhale, S.2    Rampy, B.A.3    Adegboyega, P.4    Duarte, A.5    Saldana, M.J.6
  • 350
    • 1342289333 scopus 로고    scopus 로고
    • Pulmonary hypertension in sickle cell disease
    • Vichinsky EP. Pulmonary hypertension in sickle cell disease. N Engl J Med 2004;350:857-9.
    • (2004) N Engl J Med , vol.350 , pp. 857-859
    • Vichinsky, E.P.1
  • 351
    • 20044395385 scopus 로고    scopus 로고
    • Pulmonary hypertension in SS, SC and Sβ thalassemia: Prevalence, associated clinical syndromes and mortality
    • Castro LM, Jonassiant JC, Graham FL, Ashley-Koch A, Tellen MJ. Pulmonary hypertension in SS, SC and Sβ thalassemia: Prevalence, associated clinical syndromes and mortality. Blood 2004;104:462a.
    • (2004) Blood , vol.104
    • Castro, L.M.1    Jonassiant, J.C.2    Graham, F.L.3    Ashley-Koch, A.4    Tellen, M.J.5
  • 352
    • 20044386727 scopus 로고    scopus 로고
    • Chronic sickle cell lung disease: New insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension
    • Machado RF, Gladwin MT. Chronic sickle cell lung disease: New insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension. Br J Haematol 2005;129:449-64.
    • (2005) Br J Haematol , vol.129 , pp. 449-464
    • Machado, R.F.1    Gladwin, M.T.2
  • 356
    • 0035097599 scopus 로고    scopus 로고
    • Prognostic factors in medically treated patients with chronic pulmonary embolism
    • Lewczuk J, Piszko P, Jagas J, Porada A, Wojciak S, Sobkowicz B, et al. Prognostic factors in medically treated patients with chronic pulmonary embolism. Chest 2001;119:818-23.
    • (2001) Chest , vol.119 , pp. 818-823
    • Lewczuk, J.1    Piszko, P.2    Jagas, J.3    Porada, A.4    Wojciak, S.5    Sobkowicz, B.6
  • 359
    • 33748750716 scopus 로고    scopus 로고
    • Bosentan in inoperable chronic thromboembolic pulmonary hypertension: Efficacy at 1 year
    • Hughes RJ, Jais X, Bonderman D, Suntharalingam J, Humbert M, Lang I, et al. Bosentan in inoperable chronic thromboembolic pulmonary hypertension: Efficacy at 1 year. Eur Respir J 2006;28:138-43.
    • (2006) Eur Respir J , vol.28 , pp. 138-143
    • Hughes, R.J.1    Jais, X.2    Bonderman, D.3    Suntharalingam, J.4    Humbert, M.5    Lang, I.6
  • 360
    • 27144434777 scopus 로고    scopus 로고
    • Bosentan therapy for inoperable chronic hromboembolic pulmonary hypertension
    • Hoeper MM, Kramm T, Wilkens H, Schulze C, Schafers HJ, Welte T, et al. Bosentan therapy for inoperable chronic hromboembolic pulmonary hypertension. Chest 2005;128:2363-7.
    • (2005) Chest , vol.128 , pp. 2363-2367
    • Hoeper, M.M.1    Kramm, T.2    Wilkens, H.3    Schulze, C.4    Schafers, H.J.5    Welte, T.6
  • 361
    • 13844315727 scopus 로고    scopus 로고
    • Early haemodynamic benefit of sildenafil in patients with coexisting chronic thromboembolic pulmonary hypertension and left ventricular dysfunction
    • Sheth A, Park JE, Ong YE, Ho TB, Madden BP. Early haemodynamic benefit of sildenafil in patients with coexisting chronic thromboembolic pulmonary hypertension and left ventricular dysfunction. Vasc Pharmacol 2005;42:41-5.
    • (2005) Vasc Pharmacol , vol.42 , pp. 41-45
    • Sheth, A.1    Park, J.E.2    Ong, Y.E.3    Ho, T.B.4    Madden, B.P.5
  • 362
    • 0038555341 scopus 로고    scopus 로고
    • Effect of orally active prostacyclin analogue on survival in patients with chronic thromboembolic pulmonary hypertension without major vessel obstruction
    • Ono F, Nagaya N, Okumura H, Shimizu Y, Kyotani S, Nakanishi N, et al. Effect of orally active prostacyclin analogue on survival in patients with chronic thromboembolic pulmonary hypertension without major vessel obstruction. Chest 2003;123:1583-8.
    • (2003) Chest , vol.123 , pp. 1583-1588
    • Ono, F.1    Nagaya, N.2    Okumura, H.3    Shimizu, Y.4    Kyotani, S.5    Nakanishi, N.6
  • 363
    • 16644387305 scopus 로고    scopus 로고
    • Epoprostenol in chronic thromboembolic pulmonary hypertension with distal lesions
    • Scelsi L, Ghio S, Campana C, D'Armini AM, Serio A, Klersy C, et al. Epoprostenol in chronic thromboembolic pulmonary hypertension with distal lesions. Ital Heart J 2004;5:618-23.
    • (2004) Ital Heart J , vol.5 , pp. 618-623
    • Scelsi, L.1    Ghio, S.2    Campana, C.3    D'Armini, A.M.4    Serio, A.5    Klersy, C.6
  • 364
    • 0041828932 scopus 로고    scopus 로고
    • Inhaled iloprost in patients with chronic thromboembolic pulmonary hypertension: Effects before and after pulmonary thromboendarterectomy
    • Kramm T, Eberle B, Krummenauer F, Guth S, Oelert H, Mayer E. Inhaled iloprost in patients with chronic thromboembolic pulmonary hypertension: Effects before and after pulmonary thromboendarterectomy. Ann Thorac Surg 2003;76:711-8.
    • (2003) Ann Thorac Surg , vol.76 , pp. 711-718
    • Kramm, T.1    Eberle, B.2    Krummenauer, F.3    Guth, S.4    Oelert, H.5    Mayer, E.6
  • 365
    • 0037331512 scopus 로고    scopus 로고
    • Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension
    • Nagaya N, Sasaki N, Ando M, Ogino H, Sakamaki F, Kyotani S, et al. Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension. Chest 2003;123:338-43.
    • (2003) Chest , vol.123 , pp. 338-343
    • Nagaya, N.1    Sasaki, N.2    Ando, M.3    Ogino, H.4    Sakamaki, F.5    Kyotani, S.6
  • 367
    • 0037389118 scopus 로고    scopus 로고
    • Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension
    • Stiebellehner L, Petkov V, Vonbank K, Funk G, Schenk P, Ziesche R, et al. Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension. Chest 2003;123:1293-5.
    • (2003) Chest , vol.123 , pp. 1293-1295
    • Stiebellehner, L.1    Petkov, V.2    Vonbank, K.3    Funk, G.4    Schenk, P.5    Ziesche, R.6
  • 368
    • 0242266583 scopus 로고    scopus 로고
    • Hypoxaemia in sickle cell disease: Biomarker modulation and relevance to pathophysiology
    • Setty BN, Stuart MJ, Dampier C, Brodecki D, Allen JL. Hypoxaemia in sickle cell disease: Biomarker modulation and relevance to pathophysiology. Lancet 2003;362:1450-5.
    • (2003) Lancet , vol.362 , pp. 1450-1455
    • Setty, B.N.1    Stuart, M.J.2    Dampier, C.3    Brodecki, D.4    Allen, J.L.5
  • 369
    • 0042805260 scopus 로고    scopus 로고
    • Hemolytic anemia-associated pulmonary hypertension of sickle cell disease and the nitric oxide/arginine pathway
    • Jison ML, Gladwin MT. Hemolytic anemia-associated pulmonary hypertension of sickle cell disease and the nitric oxide/arginine pathway. Am J Respir Crit Care Med 2003;168:3-4.
    • (2003) Am J Respir Crit Care Med , vol.168 , pp. 3-4
    • Jison, M.L.1    Gladwin, M.T.2
  • 373
    • 20044368380 scopus 로고    scopus 로고
    • Pulmonary hypertension in sickle cell disease: Cardiopulmonary evaluation and response to chronic phosphodiasterase 5 inhibitor therapy
    • Machado RF, Martyr SE, Anthi A, Kato GJ, Hunter LA, Coles WA, et al. Pulmonary hypertension in sickle cell disease: Cardiopulmonary evaluation and response to chronic phosphodiasterase 5 inhibitor therapy. Blood 2004;104:71.
    • (2004) Blood , vol.104 , pp. 71
    • Machado, R.F.1    Martyr, S.E.2    Anthi, A.3    Kato, G.J.4    Hunter, L.A.5    Coles, W.A.6
  • 374
    • 0037630072 scopus 로고    scopus 로고
    • Obstructive sleep apnea and cardiovascular disease
    • Lattimore JD, Celermajer DS, Wilcox I. Obstructive sleep apnea and cardiovascular disease. J Am Coll Cardio I 2003;41:1429-37.
    • (2003) J Am Coll Cardio , vol.1 , Issue.41 , pp. 1429-1437
    • Lattimore, J.D.1    Celermajer, D.S.2    Wilcox, I.3
  • 375
    • 2142771733 scopus 로고    scopus 로고
    • Risk factors for obstructive sleep apnea in adults
    • Young T, Skatrud J, Peppard PE. Risk factors for obstructive sleep apnea in adults. JAMA 2004;291:2013.
    • (2004) JAMA , vol.291 , pp. 2013
    • Young, T.1    Skatrud, J.2    Peppard, P.E.3
  • 377
    • 0029949783 scopus 로고    scopus 로고
    • pulmonary hypertension in the obstructive sleep apnea syndrome: Prevalence, causes and therapeutic consequences
    • Kessler R, Chaouat A, Weitzenblum E, Oswald M, Ehrhart M, Apprill M, et al. pulmonary hypertension in the obstructive sleep apnea syndrome: Prevalence, causes and therapeutic consequences. Eur Respir J 1996;9:787-94.
    • (1996) Eur Respir J , vol.9 , pp. 787-794
    • Kessler, R.1    Chaouat, A.2    Weitzenblum, E.3    Oswald, M.4    Ehrhart, M.5    Apprill, M.6
  • 378
    • 0035685436 scopus 로고    scopus 로고
    • Daytime pulmonary hypertension in patients with obstructive apnea: The effect of continous positive airway pressure on pulmonary hemodynamics
    • Alchanatis M, Tourkohoriti G, Kakouros S, Kosmas E, Podaras S, Jordanoglou JB. Daytime pulmonary hypertension in patients with obstructive apnea: The effect of continous positive airway pressure on pulmonary hemodynamics. Respiration 2001;68:666-72.
    • (2001) Respiration , vol.68 , pp. 666-672
    • Alchanatis, M.1    Tourkohoriti, G.2    Kakouros, S.3    Kosmas, E.4    Podaras, S.5    Jordanoglou, J.B.6
  • 379
    • 0021812749 scopus 로고
    • Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome
    • Bradley TD, Rutherford R, Grossman RF, Lue F, Zamel N, Moldofsky H, et al. Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. Am Rev Respir Dis 1985;131:835-9.
    • (1985) Am Rev Respir Dis , vol.131 , pp. 835-839
    • Bradley, T.D.1    Rutherford, R.2    Grossman, R.F.3    Lue, F.4    Zamel, N.5    Moldofsky, H.6
  • 382
    • 0034821544 scopus 로고    scopus 로고
    • The obesity-hypoventilation syndrome revisited: A prospective study of 34 consecutive cases
    • Kessler R, Chaouat A, Schinkewitch P, Faller M, Casel S, Krieger J, et al. The obesity-hypoventilation syndrome revisited: A prospective study of 34 consecutive cases. Chest 2001;120:369-76.
    • (2001) Chest , vol.120 , pp. 369-376
    • Kessler, R.1    Chaouat, A.2    Schinkewitch, P.3    Faller, M.4    Casel, S.5    Krieger, J.6
  • 383
    • 33646239843 scopus 로고    scopus 로고
    • Pulmonary hypertension in obstructive sleep apnoea: Effects of continuous positive airway pressure: A randomized, controlled cross-over study
    • Arias MA, Garcia-Rio F, Alonso-Fernandez A, Martínez I, Villamor J. Pulmonary hypertension in obstructive sleep apnoea: Effects of continuous positive airway pressure: A randomized, controlled cross-over study. Eur Heart J 2006;27:1106-13.
    • (2006) Eur Heart J , vol.27 , pp. 1106-1113
    • Arias, M.A.1    Garcia-Rio, F.2    Alonso-Fernandez, A.3    Martínez, I.4    Villamor, J.5
  • 385
    • 0011678175 scopus 로고
    • Chronic, massive thrombotic obstruction of the pulmonary arteries: Analysis of four operated cases
    • Moser KM, Houk VN, Jones RC, Hufnagel CC. Chronic, massive thrombotic obstruction of the pulmonary arteries: Analysis of four operated cases. Circulation 1965;32:377-85.
    • (1965) Circulation , vol.32 , pp. 377-385
    • Moser, K.M.1    Houk, V.N.2    Jones, R.C.3    Hufnagel, C.C.4
  • 386
    • 0014605153 scopus 로고
    • Embolectomy for chronic PE and pulmonary hypertension
    • Moor GF, Sabiston DC Jr. Embolectomy for chronic PE and pulmonary hypertension. Rev Surg 1969;26:449-51.
    • (1969) Rev Surg , vol.26 , pp. 449-451
    • Moor, G.F.1    Sabiston Jr., D.C.2
  • 387
    • 0020075903 scopus 로고
    • Long term follow-up of patients with pulmonary thromboembolism: Late prognosis and evolution of hemodynamic and respiratory data
    • Riedel M, Stanek V, Widimsky J, Prerovsky I. Long term follow-up of patients with pulmonary thromboembolism: Late prognosis and evolution of hemodynamic and respiratory data. Chest 1982;81:151-8.
    • (1982) Chest , vol.81 , pp. 151-158
    • Riedel, M.1    Stanek, V.2    Widimsky, J.3    Prerovsky, I.4
  • 389
    • 33748765846 scopus 로고    scopus 로고
    • Pulmonary microvascular disease in CTEPH
    • Galie N, Kim NH. Pulmonary microvascular disease in CTEPH. Proc Am Thorac Soc 2006;3:571-6.
    • (2006) Proc Am Thorac Soc , vol.3 , pp. 571-576
    • Galie, N.1    Kim, N.H.2
  • 391
    • 34547456414 scopus 로고    scopus 로고
    • The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted
    • Bonnet S, Rochefort G, Sutendra G, Archer SL, Haromy A, Webster L, et al. The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted. Proc Natl Acad Sci USA 2007;104:11418-23.
    • (2007) Proc Natl Acad Sci USA , vol.104 , pp. 11418-11423
    • Bonnet, S.1    Rochefort, G.2    Sutendra, G.3    Archer, S.L.4    Haromy, A.5    Webster, L.6
  • 392
    • 0034062248 scopus 로고    scopus 로고
    • The natural history of acute and chronic thromboembolic disease: The search for the missing link
    • Fedullo PF, Rubin LJ, Kerr KM, Auger WR, Channick RN. The natural history of acute and chronic thromboembolic disease: The search for the missing link. Eur Respir J 2000;15:435-7.
    • (2000) Eur Respir J , vol.15 , pp. 435-437
    • Fedullo, P.F.1    Rubin, L.J.2    Kerr, K.M.3    Auger, W.R.4    Channick, R.N.5
  • 394
    • 2442695226 scopus 로고    scopus 로고
    • Chronic thromboembolic pulmonary hypertension: Not so rare after all
    • Lang IM. Chronic thromboembolic pulmonary hypertension: Not so rare after all. N Engl J Med 2004;350:2236-8.
    • (2004) N Engl J Med , vol.350 , pp. 2236-2238
    • Lang, I.M.1
  • 395
    • 0025293720 scopus 로고
    • Chronic major-vessel thromboembolic pulmonary hypertension
    • Moser KM, Auger WR, Fedullo PF. Chronic major-vessel thromboembolic pulmonary hypertension. Circulation 1990;81:1735-43.
    • (1990) Circulation , vol.81 , pp. 1735-1743
    • Moser, K.M.1    Auger, W.R.2    Fedullo, P.F.3
  • 396
    • 33746780016 scopus 로고    scopus 로고
    • Right ventricular function assessed by two-dimensional strain and tissue doppler echocardiography in patients with pulmonary arterial hypertension and effect of vasodilator therapy
    • Borges AC, Knebel F, Eddicks S, Panda A, Schattke S, Witt C, et al. Right ventricular function assessed by two-dimensional strain and tissue doppler echocardiography in patients with pulmonary arterial hypertension and effect of vasodilator therapy. Am J Cardiol 2006;98:530-4.
    • (2006) Am J Cardiol , vol.98 , pp. 530-534
    • Borges, A.C.1    Knebel, F.2    Eddicks, S.3    Panda, A.4    Schattke, S.5    Witt, C.6
  • 397
    • 0034059493 scopus 로고    scopus 로고
    • Is pulmonary embolism a common cause of chronic pulmonary hypertension? Limitations of the embolic hypothesis
    • Egermayer P, Peacock AJ. Is pulmonary embolism a common cause of chronic pulmonary hypertension? Limitations of the embolic hypothesis. Eur Respir J 2000;15:440-8.
    • (2000) Eur Respir J , vol.15 , pp. 440-448
    • Egermayer, P.1    Peacock, A.J.2
  • 399
    • 33845343982 scopus 로고    scopus 로고
    • Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers
    • Hoeper MH, Lee SH, Voswinckel R, Palazzini M, Jais X, Marinelli A, et al. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol 2006;48:2546-52.
    • (2006) J Am Coll Cardiol , vol.48 , pp. 2546-2552
    • Hoeper, M.H.1    Lee, S.H.2    Voswinckel, R.3    Palazzini, M.4    Jais, X.5    Marinelli, A.6
  • 400
    • 0034970144 scopus 로고    scopus 로고
    • Recurrent thromboembolic disease following splenectomy for pyruvate kinase deficiency
    • Chou R, DeLoughery TG. Recurrent thromboembolic disease following splenectomy for pyruvate kinase deficiency. Am J Hematol 2001;67:197-9.
    • (2001) Am J Hematol , vol.67 , pp. 197-199
    • Chou, R.1    DeLoughery, T.G.2
  • 401
    • 10744232963 scopus 로고    scopus 로고
    • An extreme consequence of splenectomy in dehydrated hereditary stomatocytosis: Gradual thrombo-embolic pulmonary hypertension and lung-heart transplantation
    • Jais X, Till SJ, Cynober T, Ioos V, Gaecia G, Tchernia G, et al. An extreme consequence of splenectomy in dehydrated hereditary stomatocytosis: Gradual thrombo-embolic pulmonary hypertension and lung-heart transplantation. Hemoglobin 2003;27:139-47.
    • (2003) Hemoglobin , vol.27 , pp. 139-147
    • Jais, X.1    Till, S.J.2    Cynober, T.3    Ioos, V.4    Gaecia, G.5    Tchernia, G.6
  • 402
    • 0036007307 scopus 로고    scopus 로고
    • Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery
    • Clapp LH, Finney P, Turcato S, Tran S, Rubin LJ, Tinker A. Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery. Am J Respir Cell Mol Biol 2002;26:194-201.
    • (2002) Am J Respir Cell Mol Biol , vol.26 , pp. 194-201
    • Clapp, L.H.1    Finney, P.2    Turcato, S.3    Tran, S.4    Rubin, L.J.5    Tinker, A.6
  • 403
    • 0021246369 scopus 로고
    • Differentiation of patients with primary and thromboembolic pulmonary hypertension
    • D'Alonzo GE, Bower JS, Dantzker DR. Differentiation of patients with primary and thromboembolic pulmonary hypertension. Chest 1984;85:457-61.
    • (1984) Chest , vol.85 , pp. 457-461
    • D'Alonzo, G.E.1    Bower, J.S.2    Dantzker, D.R.3
  • 405
    • 0030765834 scopus 로고    scopus 로고
    • Chronic thromboembolism: Diagnosis with helical CT and MR imaging with angiographic and surgical correlation
    • Bergin CJ, Sirlin CB, Hauschildt JP, Huynh TV, Auger WR, Fedullo PF, et al. Chronic thromboembolism: Diagnosis with helical CT and MR imaging with angiographic and surgical correlation. Radiology 1997;204:695-702.
    • (1997) Radiology , vol.204 , pp. 695-702
    • Bergin, C.J.1    Sirlin, C.B.2    Hauschildt, J.P.3    Huynh, T.V.4    Auger, W.R.5    Fedullo, P.F.6
  • 406
    • 12844272424 scopus 로고    scopus 로고
    • Safety and tolerability of bosentan in adults with Eisenmenger physiology
    • Gatzoulis, MA, Rogers P, Li W, Harries C, Cramer D, Ward S, et al. Safety and tolerability of bosentan in adults with Eisenmenger physiology. Int J Cardiol 2005;98:147-51.
    • (2005) Int J Cardiol , vol.98 , pp. 147-151
    • Gatzoulis, M.A.1    Rogers, P.2    Li, W.3    Harries, C.4    Cramer, D.5    Ward, S.6
  • 409
    • 33746584053 scopus 로고    scopus 로고
    • Sildenafil: From angina to erectile dysfunction to pulmonary hypertension and beyond
    • Ghofrani HA, Osterloh IH, Grimminger F. Sildenafil: From angina to erectile dysfunction to pulmonary hypertension and beyond. Nat Rev Drug Discov 2006;5:689-702.
    • (2006) Nat Rev Drug Discov , vol.5 , pp. 689-702
    • Ghofrani, H.A.1    Osterloh, I.H.2    Grimminger, F.3
  • 410
    • 0028323086 scopus 로고
    • MR imaging with spatial modulation of magnetization in the evaluation of chronic central pulmonary thromboemboli
    • Hatabu H, Gefter WB, Axel L, Palevsky HI, Cope C, Reichek N, et al. MR imaging with spatial modulation of magnetization in the evaluation of chronic central pulmonary thromboemboli. Radiology 1994;190:791-6.
    • (1994) Radiology , vol.190 , pp. 791-796
    • Hatabu, H.1    Gefter, W.B.2    Axel, L.3    Palevsky, H.I.4    Cope, C.5    Reichek, N.6
  • 411
    • 34548215143 scopus 로고    scopus 로고
    • Effect of sildenafil on ventilatory efficiency and exercise tolerance in pulmonary hypertension
    • Oudiz RJ, Roveran G, Hansen JE, Sun XG, Wasserman K. Effect of sildenafil on ventilatory efficiency and exercise tolerance in pulmonary hypertension. Eur J Heart Fail 2007;9:917-21.
    • (2007) Eur J Heart Fail , vol.9 , pp. 917-921
    • Oudiz, R.J.1    Roveran, G.2    Hansen, J.E.3    Sun, X.G.4    Wasserman, K.5
  • 412
    • 33646489801 scopus 로고    scopus 로고
    • Nonarteritic anterior ischemic optic neuropathy and sildenafil
    • Fraunfelder FW, Pomeranz HD, Egan RA. Nonarteritic anterior ischemic optic neuropathy and sildenafil. Arch Ophthalmol 2006;124:733-4.
    • (2006) Arch Ophthalmol , vol.124 , pp. 733-734
    • Fraunfelder, F.W.1    Pomeranz, H.D.2    Egan, R.A.3
  • 413
    • 0032080555 scopus 로고    scopus 로고
    • Noninvasive differential diagnosis between chronic pulmonary thromboembolism and primary pulmonary hypertension by means of Doppler ultrasound measurement
    • Nakayama Y, Sugimachi M, Nakanishi N, Takaki H, Okano Y, Satoh T, et al. Noninvasive differential diagnosis between chronic pulmonary thromboembolism and primary pulmonary hypertension by means of Doppler ultrasound measurement. J Am Coll Cardiol 1998;31:1367-71.
    • (1998) J Am Coll Cardiol , vol.31 , pp. 1367-1371
    • Nakayama, Y.1    Sugimachi, M.2    Nakanishi, N.3    Takaki, H.4    Okano, Y.5    Satoh, T.6
  • 415
    • 20244386797 scopus 로고    scopus 로고
    • Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension
    • Langleben D, Christman BW, Barst RJ, Dias VC, Galiè N, Higenbottam TW, et al. Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension. Am Heart J 2002;143:E4.
    • (2002) Am Heart J , vol.143
    • Langleben, D.1    Christman, B.W.2    Barst, R.J.3    Dias, V.C.4    Galiè, N.5    Higenbottam, T.W.6
  • 418
    • 34247171239 scopus 로고    scopus 로고
    • Atrial septostomy improves survival in select patients with pulmonary hypertension
    • Law MA, Grifka RG, Mullins CE, Nihill MR. Atrial septostomy improves survival in select patients with pulmonary hypertension. Am Heart J 2007;153:779-84.
    • (2007) Am Heart J , vol.153 , pp. 779-784
    • Law, M.A.1    Grifka, R.G.2    Mullins, C.E.3    Nihill, M.R.4
  • 419
    • 33748767420 scopus 로고    scopus 로고
    • Assessment of operability in chronic thromboembolic pulmonary hypertension
    • Kim NH. Assessment of operability in chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 2006;3:584-8.
    • (2006) Proc Am Thorac Soc , vol.3 , pp. 584-588
    • Kim, N.H.1
  • 420
    • 0346096812 scopus 로고    scopus 로고
    • Pre-operative partitioning of pulmonary vascular resistance correlates with early outcome after thromboendarterectomy for chronic thromboembolic pulmonary hypertension
    • Kim NH, Fesler P, Channick RN, Knowlton KU, Ben-Yehuda O, Lee SH, et al. Pre-operative partitioning of pulmonary vascular resistance correlates with early outcome after thromboendarterectomy for chronic thromboembolic pulmonary hypertension. Circulation 2004;109:18-22.
    • (2004) Circulation , vol.109 , pp. 18-22
    • Kim, N.H.1    Fesler, P.2    Channick, R.N.3    Knowlton, K.U.4    Ben-Yehuda, O.5    Lee, S.H.6
  • 421
    • 33745792342 scopus 로고    scopus 로고
    • Presentation, survival prospects and predictors of death in Eisenmenger syndrome: A combined retrospective and case-control study
    • Diller GP, Dimopoulos K, Broberg GS, Kaya MG, Naghotra US, Uebing A, et al. Presentation, survival prospects and predictors of death in Eisenmenger syndrome: A combined retrospective and case-control study. Eur Heart J 2006;27:1737-42.
    • (2006) Eur Heart J , vol.27 , pp. 1737-1742
    • Diller, G.P.1    Dimopoulos, K.2    Broberg, G.S.3    Kaya, M.G.4    Naghotra, U.S.5    Uebing, A.6
  • 422
    • 4444294201 scopus 로고    scopus 로고
    • Responsiveness to inhaled nitric oxide is a predictor for mid-term survival in adult patients with congenital heart defects and pulmonary arterial hypertension
    • Post MC, Janssens S, Van de Werf F, Budts W. Responsiveness to inhaled nitric oxide is a predictor for mid-term survival in adult patients with congenital heart defects and pulmonary arterial hypertension. Eur Heart J 2004;25:1651-6.
    • (2004) Eur Heart J , vol.25 , pp. 1651-1656
    • Post, M.C.1    Janssens, S.2    Van de Werf, F.3    Budts, W.4
  • 423
    • 0035097599 scopus 로고    scopus 로고
    • Prognostic factors in medically treated patients with chronic pulmonary embolism
    • Lewczuk J, Piszko P, Jagas J, Porada A, Wojciak S, Sobkowicz B, et al. Prognostic factors in medically treated patients with chronic pulmonary embolism. Chest 2001;119:818-23.
    • (2001) Chest , vol.119 , pp. 818-823
    • Lewczuk, J.1    Piszko, P.2    Jagas, J.3    Porada, A.4    Wojciak, S.5    Sobkowicz, B.6
  • 426
    • 0037311187 scopus 로고    scopus 로고
    • diagnosis of portopulmonary hypertension in candidates for liver transplantation: A prospective study
    • Colle IO, Moreau R, Godinho E, Belghiti J, Ettori F, Cohen-Solal A, et al. diagnosis of portopulmonary hypertension in candidates for liver transplantation: A prospective study. Hepatology 2003;37:401-9.
    • (2003) Hepatology , vol.37 , pp. 401-409
    • Colle, I.O.1    Moreau, R.2    Godinho, E.3    Belghiti, J.4    Ettori, F.5    Cohen-Solal, A.6
  • 427
    • 27144434777 scopus 로고    scopus 로고
    • Bosentan therapy for inoperable chronic hromboembolic pulmonary hypertension
    • Hoeper MM, Kramm T, Wilkens H, Schulze C, Schafers HJ, Welte T, et al. Bosentan therapy for inoperable chronic hromboembolic pulmonary hypertension. Chest 2005;128:2363-7.
    • (2005) Chest , vol.128 , pp. 2363-2367
    • Hoeper, M.M.1    Kramm, T.2    Wilkens, H.3    Schulze, C.4    Schafers, H.J.5    Welte, T.6
  • 428
    • 13844315727 scopus 로고    scopus 로고
    • Early haemodynamic benefit of sildenafil in patients with coexisting chronic thromboembolic pulmonary hypertension and left ventricular dysfunction
    • Sheth A, Park JE, Ong YE, Ho TB, Madden BP. Early haemodynamic benefit of sildenafil in patients with coexisting chronic thromboembolic pulmonary hypertension and left ventricular dysfunction. Vasc Pharmacol 2005;42:41-5.
    • (2005) Vasc Pharmacol , vol.42 , pp. 41-45
    • Sheth, A.1    Park, J.E.2    Ong, Y.E.3    Ho, T.B.4    Madden, B.P.5
  • 429
    • 0038555341 scopus 로고    scopus 로고
    • Effect of orally active prostacyclin analogue on survival in patients with chronic thromboembolic pulmonary hypertension without major vessel obstruction
    • Ono F, Nagaya N, Okumura H, Shimizu Y, Kyotani S, Nakanishi N, et al. Effect of orally active prostacyclin analogue on survival in patients with chronic thromboembolic pulmonary hypertension without major vessel obstruction. Chest 2003;123:1583-8.
    • (2003) Chest , vol.123 , pp. 1583-1588
    • Ono, F.1    Nagaya, N.2    Okumura, H.3    Shimizu, Y.4    Kyotani, S.5    Nakanishi, N.6
  • 430
    • 16644387305 scopus 로고    scopus 로고
    • Epoprostenol in chronic thromboembolic pulmonary hypertension with distal lesions
    • Scelsi L, Ghio S, Campana C, D'Armini AM, Serio A, Klersy C, et al. Epoprostenol in chronic thromboembolic pulmonary hypertension with distal lesions. Ital Heart J 2004;5:618-23.
    • (2004) Ital Heart J , vol.5 , pp. 618-623
    • Scelsi, L.1    Ghio, S.2    Campana, C.3    D'Armini, A.M.4    Serio, A.5    Klersy, C.6
  • 431
    • 0041828932 scopus 로고    scopus 로고
    • Inhaled iloprost in patients with chronic thromboembolic pulmonary hypertension: Effects before and after pulmonary thromboendarterectomy
    • Kramm T, Eberle B, Krummenauer F, Guth S, Oelert H, Mayer E. Inhaled iloprost in patients with chronic thromboembolic pulmonary hypertension: Effects before and after pulmonary thromboendarterectomy. Ann Thorac Surg 2003;76:711-8.
    • (2003) Ann Thorac Surg , vol.76 , pp. 711-718
    • Kramm, T.1    Eberle, B.2    Krummenauer, F.3    Guth, S.4    Oelert, H.5    Mayer, E.6
  • 432
    • 0037331512 scopus 로고    scopus 로고
    • Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension
    • Nagaya N, Sasaki N, Ando M, Ogino H, Sakamaki F, Kyotani S, et al. Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension. Chest 2003;123:338-43.
    • (2003) Chest , vol.123 , pp. 338-343
    • Nagaya, N.1    Sasaki, N.2    Ando, M.3    Ogino, H.4    Sakamaki, F.5    Kyotani, S.6
  • 434
    • 0037389118 scopus 로고    scopus 로고
    • Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension
    • Stiebellehner L, Petkov V, Vonbank K, Funk G, Schenk P, Ziesche R, et al. Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension. Chest 2003;123:1293-5.
    • (2003) Chest , vol.123 , pp. 1293-1295
    • Stiebellehner, L.1    Petkov, V.2    Vonbank, K.3    Funk, G.4    Schenk, P.5    Ziesche, R.6
  • 435
    • 0035943014 scopus 로고    scopus 로고
    • Exercise pathophysiology in patients with primary pulmonary hypertension
    • Sun XG, Hansen JE, Oudiz RJ, Wasserman K. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation 2001;104:429-35.
    • (2001) Circulation , vol.104 , pp. 429-435
    • Sun, X.G.1    Hansen, J.E.2    Oudiz, R.J.3    Wasserman, K.4
  • 436
    • 0032491187 scopus 로고    scopus 로고
    • Dysfunctional voltage-gated K+ channels in pulmonary artery smooth muscle cells of patients with primary pulmonary hypertension
    • Yuan JX, Aldinger AM, Juhaszova M, Wang J, Conte JV Jr, Gaine SP, et al. Dysfunctional voltage-gated K+ channels in pulmonary artery smooth muscle cells of patients with primary pulmonary hypertension. Circulation 1998;98:1400-6.
    • (1998) Circulation , vol.98 , pp. 1400-1406
    • Yuan, J.X.1    Aldinger, A.M.2    Juhaszova, M.3    Wang, J.4    Conte Jr, J.V.5    Gaine, S.P.6
  • 437
    • 0038306324 scopus 로고    scopus 로고
    • Proximal pulmonary arterial and intrapulmonary radiologic features of Eisenmenger syndrome and primary pulmonary hypertension
    • Perloff JK, Hart EM, Greaves SM, Miner PD, Child JS. Proximal pulmonary arterial and intrapulmonary radiologic features of Eisenmenger syndrome and primary pulmonary hypertension. Am J Cardiol 2003;92:182-7.
    • (2003) Am J Cardiol , vol.92 , pp. 182-187
    • Perloff, J.K.1    Hart, E.M.2    Greaves, S.M.3    Miner, P.D.4    Child, J.S.5
  • 438
    • 10044258461 scopus 로고    scopus 로고
    • Guidelines on diagnosis and treatment of pulmonary arterial hypertension (The task force on diagnosis and treatment of pulmonary arterial hypertension of the European Society of Cardiology)
    • Galie N, Torbicki A, Barst R, Dartevelle P, Haworth S, Higenbottam T, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension (The task force on diagnosis and treatment of pulmonary arterial hypertension of the European Society of Cardiology). Eur Heart J 2004;25:2243-78.
    • (2004) Eur Heart J , vol.25 , pp. 2243-2278
    • Galie, N.1    Torbicki, A.2    Barst, R.3    Dartevelle, P.4    Haworth, S.5    Higenbottam, T.6
  • 439
    • 0034803780 scopus 로고    scopus 로고
    • Medical therapy of pulmonary hypertension. Conventional therapies
    • Naeije R, Vachiéry JL. Medical therapy of pulmonary hypertension. Conventional therapies. Clin Chest Med 2001;22:517-27.
    • (2001) Clin Chest Med , vol.22 , pp. 517-527
    • Naeije, R.1    Vachiéry, J.L.2
  • 441
    • 0031950190 scopus 로고    scopus 로고
    • Utility of CT scan evaluation for predicting pulmonary hypertension in patients with parenchymal lung disease
    • Tan RT, Kuzo R, Goodman LR, Siegel R, Haasler GB, Presberg KW. Utility of CT scan evaluation for predicting pulmonary hypertension in patients with parenchymal lung disease. Chest 1998;113:1250-6.
    • (1998) Chest , vol.113 , pp. 1250-1256
    • Tan, R.T.1    Kuzo, R.2    Goodman, L.R.3    Siegel, R.4    Haasler, G.B.5    Presberg, K.W.6
  • 442
    • 0034045095 scopus 로고    scopus 로고
    • The use of high resolution computed tomography in the evaluation of pulmonary hemodynamics in patients with congenital heart disease: In pulmonary vessels larger than 1 mm in diameter
    • Choe KO, Hong YK, Kim HJ, Joo SH, Cho BK, Chang BC, et al. The use of high resolution computed tomography in the evaluation of pulmonary hemodynamics in patients with congenital heart disease: In pulmonary vessels larger than 1 mm in diameter. Pediatr Cardiol 2000;21:202-10.
    • (2000) Pediatr Cardiol , vol.21 , pp. 202-210
    • Choe, K.O.1    Hong, Y.K.2    Kim, H.J.3    Joo, S.H.4    Cho, B.K.5    Chang, B.C.6
  • 443
    • 0032888228 scopus 로고    scopus 로고
    • A CT sign of chronic pulmonary arterial hypertension: The ratio of main pulmonary artery to aortic diameter
    • Ng CS, Wells AU, Padley SP. A CT sign of chronic pulmonary arterial hypertension: The ratio of main pulmonary artery to aortic diameter. J Thorac Imaging 1999;14:270-8.
    • (1999) J Thorac Imaging , vol.14 , pp. 270-278
    • Ng, C.S.1    Wells, A.U.2    Padley, S.P.3
  • 444
    • 0032914995 scopus 로고    scopus 로고
    • Pericardial thickening or effusion in patients with pulmonary artery hypertension: A CT study
    • Baque-Juston MC, Wells AU, Hansell DM. Pericardial thickening or effusion in patients with pulmonary artery hypertension: A CT study. AJR Am J Roentgenol 1999;172:361-4.
    • (1999) AJR Am J Roentgenol , vol.172 , pp. 361-364
    • Baque-Juston, M.C.1    Wells, A.U.2    Hansell, D.M.3
  • 445
    • 2942550678 scopus 로고    scopus 로고
    • Ambrisentan improves exercise capacity and clinical measures in pulmonary arterial hypertension (PAH)
    • Rubin LJ, Galie N, Badesch BD. Ambrisentan improves exercise capacity and clinical measures in pulmonary arterial hypertension (PAH). Am J Crit Care Med 2004;169:A210.
    • (2004) Am J Crit Care Med , vol.169
    • Rubin, L.J.1    Galie, N.2    Badesch, B.D.3
  • 446
    • 3142724657 scopus 로고    scopus 로고
    • American College of Chest Physicians. Surgical treatments/interventions for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines
    • Doyle RL, McCrory D, Channick RN, Simonneau G, Conte J; American College of Chest Physicians. Surgical treatments/interventions for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004;126:63S-71S.
    • (2004) Chest , vol.126
    • Doyle, R.L.1    McCrory, D.2    Channick, R.N.3    Simonneau, G.4    Conte, J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.